ABXBACT
Laboratory2,020 LOINC codes in this class
25185-0Streptomycin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 6.0 ug/mLL18934-0Isoniazid [Susceptibility]L30270-3Didanosine [Susceptibility] by Phenotype methodL25201-5Rifabutin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 4.0 ug/mLL72854-3Ganciclovir [Susceptibility] by Genotype methodL10653-4Clotrimazole [Susceptibility] by Minimum inhibitory concentration (MIC)L25190-0Clarithromycin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 8.0 ug/mLL30277-8Efavirenz [Susceptibility] by Phenotype methodL82512-5Hepatitis C virus genotype 1 [Type] in Serum or Plasma by NAA with probe detectionL72558-0Etravirine [Susceptibility] by Phenotype methodL30280-2Nelfinavir [Susceptibility] by Phenotype methodL41031-6Lopinavir [Susceptibility] by Genotype methodL25231-2Ethionamide [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 10.0 ug/mLL18883-9Cefonicid [Susceptibility]L25182-7Kanamycin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 5.0 ug/mLL359-0Netilmicin [Susceptibility] by Minimum inhibitory concentration (MIC)L352-5Nalidixate [Susceptibility] by Disk diffusion (KB)L25203-1rifAMPin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 2.0 ug/mLL10698-9Nystatin [Susceptibility] by Minimum lethal concentration (MLC)L7019-3Imipenem [Susceptibility] by Gradient stripL30275-2Nevirapine [Susceptibility] by Phenotype methodL332-7Mezlocillin [Susceptibility] by Disk diffusion (KB)L308-7Loracarbef [Susceptibility] by Disk diffusion (KB)L7052-4Tetracycline [Susceptibility] by Gradient stripL80691-9HIV 1 proviral DNA integrase gene mutations detected [Identifier] in Blood mononuclear cells by SequencingL396-2Penicillin V [Susceptibility] by Minimum inhibitory concentration (MIC)L25200-7Rifabutin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 2.0 ug/mLL453-1Spectinomycin [Susceptibility] by Disk diffusion (KB)L25174-4Amikacin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 8.0 ug/mLL80-2Cefixime [Susceptibility] by Minimum inhibitory concentration (MIC)L18921-7Ethambutol [Susceptibility]L80692-7HIV 1 proviral DNA reverse transcriptase and protease gene mutations detected [Identifier] in Blood mononuclear cells by SequencingL57965-6Fosamprenavir+Ritonavir [Susceptibility] by Phenotype methodL61198-8Raltegravir [Susceptibility] by Phenotype methodL77682-3Staphylococcus aureus methicillin resistance SCCmec+orfX junction [Presence] in Nose by NAA with probe detectionL473-9sulfiSOXAZOLE [Susceptibility] by Disk diffusion (KB)L58029-0Tipranavir+Ritonavir [Susceptibility] by Phenotype methodL25180-1Ciprofloxacin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 2.0 ug/mLL6979-9Ampicillin [Susceptibility] by Gradient stripL18916-7Dicloxacillin [Susceptibility]L25181-9Ciprofloxacin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 4.0 ug/mLL30268-7Zidovudine [Susceptibility] by Phenotype methodL19149-4Rifabutin [Susceptibility]L304-6Lomefloxacin [Susceptibility] by Disk diffusion (KB)L61-2Carbenicillin [Susceptibility] by Disk diffusion (KB)L49623-2Amprenavir or Fosamprenavir [Susceptibility] by Genotype methodL34644-5Tenofovir [Susceptibility] by Phenotype methodL25192-6Clarithromycin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 32.0 ug/mLL55091-3Darunavir [Susceptibility] by Genotype methodL80690-1HIV 1 proviral DNA tropism [Identifier] in Blood mononuclear cellsL25230-4Ethambutol [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 2.5 ug/mLL30272-9Stavudine [Susceptibility] by Phenotype methodL25175-1Amikacin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 16.0 ug/mLL18918-3Enoxacin [Susceptibility]L182-6Cinoxacin [Susceptibility] by Disk diffusion (KB)L101-6Cefoperazone [Susceptibility] by Disk diffusion (KB)L25186-8Pyrazinamide [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 25.0 ug/mLL256-8Foscarnet [Susceptibility]L57984-7Indinavir+Ritonavir [Susceptibility] by Phenotype methodL30273-7Abacavir [Susceptibility] by Phenotype methodL30278-6Indinavir [Susceptibility] by Phenotype methodL52128-6Cefotaxime [Susceptibility] for meningitisL37-2Azithromycin [Susceptibility] by Disk diffusion (KB)L25209-8cycloSERINE [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 30.0 ug/mLL25188-4Ciprofloxacin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 8.0 ug/mLL33333-6Colistin [Susceptibility] by Gradient stripL25210-6Capreomycin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 10.0 ug/mLL18973-8Pyrazinamide [Susceptibility]L72557-2Rilpivirine [Susceptibility] by Phenotype methodL49668-7Atazanavir [Susceptibility] by Phenotype methodL58024-1Saquinavir+Ritonavir [Susceptibility] by Phenotype methodL57907-8Atazanavir+Ritonavir [Susceptibility] by Phenotype methodL54201-9Griseofulvin [Susceptibility] by Minimum inhibitory concentration (MIC)L23642-2Trovafloxacin [Susceptibility]L31041-7Moxifloxacin [Susceptibility] by Disk diffusion (KB)L18953-0Neomycin [Susceptibility]L25187-6Ethambutol [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 7.5 ug/mLL7000-3Cephalothin [Susceptibility] by Gradient stripL18922-5Ethionamide [Susceptibility]L25176-9Amikacin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 32.0 ug/mLL23638-0Grepafloxacin [Susceptibility]L513-2Trimethoprim [Susceptibility] by Disk diffusion (KB)L82719-6Enfuvirtide [Susceptibility] by Phenotype methodL72856-8Cidofovir [Susceptibility] by Genotype methodL42500-9Fosamprenavir [Susceptibility] by Phenotype methodL25191-8Clarithromycin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 16.0 ug/mLL336-8Minocycline [Susceptibility] by Disk diffusion (KB)L97-6Cefonicid [Susceptibility] by Disk diffusion (KB)L41688-3Dalbavancin [Susceptibility] by Disk diffusion (KB)L138-8Ceftizoxime [Susceptibility] by Disk diffusion (KB)L42317-8Foscarnet [Susceptibility] by Genotype methodL25198-3Ethionamide [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 15.0 ug/mLL18881-3Cefmetazole [Susceptibility]L16623-1Clofazimine [Susceptibility] by Minimum inhibitory concentration (MIC)L57955-7Darunavir+Ritonavir [Susceptibility] by Phenotype methodL55136-6Penicillin Parenteral [Susceptibility] by Minimum inhibitory concentration (MIC)L73602-5Ceftolozane+Tazobactam [Susceptibility]L376-4Ofloxacin [Susceptibility] by Disk diffusion (KB)L83326-9HIV 1 RNA genotype and phenotype in IsolateL34643-7Lopinavir [Susceptibility] by Phenotype methodL51503-1Penicillin G procaine [Susceptibility]L33332-8Linezolid [Susceptibility] by Gradient stripL100-8Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC)L20387-7Trimethoprim+Sulfamethoxazole [Susceptibility] by Method for Slow-growing mycobacteriaL375-6Ofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)L58085-2Penicillin Parenteral [Susceptibility]L368-1Norfloxacin [Susceptibility] by Disk diffusion (KB)L25199-1Rifabutin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 1.0 ug/mLL51409-1Fosamprenavir+Ritonavir [Susceptibility] by Genotype methodL50633-7cefTRIAXone [Susceptibility] for meningitisL25219-7Isoniazid [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 1.0 ug/mLL25206-4Streptomycin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 10.0 ug/mLL82522-4Simeprevir [Susceptibility] by Genotype methodL23613-3Imipenem [Susceptibility] by Method for Slow-growing mycobacteriaL82382-3Sofosbuvir [Susceptibility] by Genotype methodL25179-3Amikacin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 6.0 ug/mLL18980-3Spectinomycin [Susceptibility]L18966-2Penicillin V [Susceptibility]L20461-0Pyrazinamide [Susceptibility] by Method for Slow-growing mycobacteriaL25800-4Tobramycin [Susceptibility] by Method for Slow-growing mycobacteriaL82514-1Hepatitis C virus genotype 3 NS5a gene mutations detected [Identifier]L30299-2Amprenavir [Susceptibility]L82523-2Grazoprevir [Susceptibility] by Genotype methodL25204-9rifAMPin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 5.0 ug/mLL25218-9Isoniazid [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 0.2 ug/mLL82381-5Hepatitis C virus genotype 1 NS5b gene mutations detected [Identifier]L10868-8Bacitracin [Susceptibility] by Disk diffusion (KB)L25195-9Ethambutol [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 10.0 ug/mLL356-6Neomycin [Susceptibility] by Disk diffusion (KB)L82521-6Paritaprevir [Susceptibility] by Genotype methodL58080-3Penicillin Parenteral [Susceptibility] for meningitisL25196-7Ethionamide [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 5.0 ug/mLL25366-6cefOXitin [Susceptibility] by Method for Slow-growing mycobacteriaL72526-7Elvitegravir [Susceptibility] by Genotype methodL72525-9Raltegravir [Susceptibility] by Genotype methodL266-7Gentamicin [Susceptibility] by Minimum lethal concentration (MLC)L40444-2CMV gene mutations detected [Identifier]L17-4Amoxicillin [Susceptibility] by Disk diffusion (KB)L18982-9Streptomycin [Susceptibility]L20377-8Ciprofloxacin [Susceptibility] by Method for Slow-growing mycobacteriaL20375-2Clarithromycin [Susceptibility] by Method for Slow-growing mycobacteriaL20373-7Amikacin [Susceptibility] by Method for Slow-growing mycobacteriaL41691-7DAPTOmycin [Susceptibility] by Gradient stripL35799-6Ertapenem [Susceptibility] by Disk diffusion (KB)L16-6Amoxicillin [Susceptibility] by Minimum inhibitory concentration (MIC)L331-9Mezlocillin [Susceptibility] by Minimum inhibitory concentration (MIC)L113-1cefoTEtan [Susceptibility] by Disk diffusion (KB)L41675-0cefOXitin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)L72860-0Telaprevir [Susceptibility] by Genotype methodL18972-0Polymyxin B [Susceptibility]L303-8Lomefloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)L7005-2Clindamycin [Susceptibility] by Gradient stripL501-7Ticarcillin [Susceptibility] by Disk diffusion (KB)L287-3Isoniazid [Susceptibility] by Minimum inhibitory concentration (MIC)L72859-2Boceprevir [Susceptibility] by Genotype methodL18912-6Colistin [Susceptibility]L16099-4Ethionamide [Susceptibility] by Minimum inhibitory concentration (MIC)L33631-3Cytomegalovirus UL54 gene mutations detected [Identifier]L72833-7Cytomegalovirus UL97 gene mutations detected [Identifier]L18880-5Cefixime [Susceptibility]L181-8Cinoxacin [Susceptibility] by Minimum inhibitory concentration (MIC)L72894-9Telavancin [Susceptibility] by Minimum inhibitory concentration (MIC)L137-0Ceftizoxime [Susceptibility] by Minimum inhibitory concentration (MIC)L20390-1Silver sulfADIAZINE [Susceptibility]L16100-0Rifabutin [Susceptibility] by Minimum inhibitory concentration (MIC)L48177-0Streptomycin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 1.0 ug/mLL35782-2Cefuroxime Oral [Susceptibility] by Disk diffusion (KB)L18874-8Cefaclor [Susceptibility]L18946-4metroNIDAZOLE [Susceptibility]L73625-6cefTAZidime+Avibactam [Susceptibility] by Minimum inhibitory concentration (MIC)L29315-9Isoniazid [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 0.4 ug/mLL25229-6Pyrazinamide [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 100.0 ug/mLL73654-6Hepatitis C virus NS3 gene mutations detected [Identifier] by Genotype methodL72857-6Dolutegravir [Susceptibility] by Genotype methodL429-1rifAMPin [Susceptibility] by Disk diffusion (KB)L512-4Trimethoprim [Susceptibility] by Minimum inhibitory concentration (MIC)L18965-4Penicillin G [Susceptibility]L50790-5HIV 1 RNA tropism [Identifier]L13968-3Penicillin [Susceptibility] by Disk diffusion (KB)L85-1Cefaclor [Susceptibility] by Disk diffusion (KB)L351-7Nalidixate [Susceptibility] by Minimum inhibitory concentration (MIC)L18920-9Erythromycin+Sulfisoxazole [Susceptibility]L68463-9Rilpivirine [Susceptibility] by Genotype methodL500-9Ticarcillin [Susceptibility] by Minimum inhibitory concentration (MIC)L20460-2Cefuroxime Oral [Susceptibility] by Minimum inhibitory concentration (MIC)L18861-5Amoxicillin [Susceptibility]L7009-4Erythromycin [Susceptibility] by Gradient stripL190-9Clarithromycin [Susceptibility] by Disk diffusion (KB)L6989-8Cefotaxime [Susceptibility] by Gradient stripL18950-6Moxalactam [Susceptibility]L253-55-Fluorocytosine [Susceptibility] by Minimum inhibitory concentration (MIC)L43279-9Hepatitis B Virus YMDD [Presence] in Serum or Plasma by NAA with probe detectionL18884-7Cefoperazone [Susceptibility]L424-2Pyrazinamide [Susceptibility] by Minimum inhibitory concentration (MIC)L226-1Doxycycline [Susceptibility] by Disk diffusion (KB)L29255-7Linezolid [Susceptibility] by Disk diffusion (KB)L409-3Piperacillin [Susceptibility] by Disk diffusion (KB)L7026-8levoFLOXacin [Susceptibility] by Gradient stripL54187-0Posaconazole [Susceptibility] by Minimum inhibitory concentration (MIC)L25217-1Isoniazid [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 0.1 ug/mLL25452-4Itraconazole [Susceptibility] by Minimum inhibitory concentration (MIC)L7049-0Streptomycin [Susceptibility] by Agar diffusion.High potencyL295-6Ketoconazole [Susceptibility] by Minimum inhibitory concentration (MIC)L7017-7Gentamicin [Susceptibility] by Agar diffusion.High potencyL57182-8HIV 1 RNA tropism [Identifier] in Plasma NarrativeL25202-3rifAMPin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 1.0 ug/mLL201-4Colistimethate by Minimum inhibitory concentration (MIC)L25194-2Ethambutol [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 5.0 ug/mLL33634-7Mycobacterium tuberculosis rifAMPin resistance gene [Identifier] in Sputum by NAA with probe detectionL45182-3HIV phenotype [Susceptibility]L112-3cefoTEtan [Susceptibility] by Minimum inhibitory concentration (MIC)L61199-6HIV 1 integrase gene mutations detected [Identifier]L25205-6Streptomycin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 2.0 ug/mLL80693-5HIV 1 proviral DNA reverse transcriptase and protease and integrase gene mutations detected [Identifier] in Blood mononuclear cells by SequencingL80695-0HIV 1 proviral DNA genotype in Mononuclear cells from whole bloodL80694-3HIV 1 proviral DNA genotype [Interpretation] in Mononuclear cells from whole blood NarrativeL42720-3Clindamycin [Susceptibility] by Agar diffusion.erythromycin induced resistanceL384-8Oxacillin [Susceptibility] by Disk diffusion (KB)L31038-3Gatifloxacin [Susceptibility]L327-7metroNIDAZOLE [Susceptibility] by Minimum inhibitory concentration (MIC)L117-2cefOXitin [Susceptibility] by Disk diffusion (KB)L280-8Imipenem [Susceptibility] by Disk diffusion (KB)L120-6Cefpodoxime [Susceptibility] by Minimum inhibitory concentration (MIC)L367-3Norfloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)L18986-0sulfiSOXAZOLE [Susceptibility]L56792-5Telbivudine [Susceptibility] by Genotype methodL56791-7Entecavir [Susceptibility] by Genotype methodL30288-5Adefovir [Susceptibility] by Genotype methodL206-3Colistin [Susceptibility] by Disk diffusion (KB)L505-8Ticarcillin+Clavulanate [Susceptibility] by Disk diffusion (KB)L81-0Cefixime [Susceptibility] by Disk diffusion (KB)L43737-6Tipranavir [Susceptibility] by Genotype methodL161-0Cephalothin [Susceptibility] by Minimum inhibitory concentration (MIC)L145-3Cefuroxime Parenteral [Susceptibility] by Minimum inhibitory concentration (MIC)L30293-5Ritonavir [Susceptibility] by Genotype methodL23611-7Para aminosalicylate [Susceptibility] by Method for Slow-growing mycobacteriaL23607-5Capreomycin [Susceptibility] by Method for Slow-growing mycobacteriaL109-9Cefotaxime [Susceptibility] by Disk diffusion (KB)L25653-7Fosfomycin [Susceptibility] by Minimum inhibitory concentration (MIC)L52749-9Etravirine [Susceptibility] by Genotype methodL421-8Polymyxin B [Susceptibility] by Disk diffusion (KB)L55617-5Other Antibiotic [Susceptibility] by Gradient stripL393-9Penicillin G [Susceptibility] by Disk diffusion (KB)L45176-5HIV nonnucleoside reverse transcriptase gene mutations detected [Identifier]L45175-7HIV nucleoside reverse transcriptase gene mutations detected [Identifier]L162-8Cephalothin [Susceptibility] by Disk diffusion (KB)L174-3Chloramphenicol [Susceptibility] by Disk diffusion (KB)L74170-2Ceftaroline [Susceptibility] by Gradient stripL49620-8lamiVUDine or Emtricitabine [Susceptibility] by Genotype methodL146-1Cefuroxime Parenteral [Susceptibility] by Disk diffusion (KB)L34700-5HIV reverse transcriptase+protease gene mutations tested forL73624-9Ceftolozane+Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC)L23608-3cycloSERINE [Susceptibility] by Method for Slow-growing mycobacteriaL18907-6Clarithromycin [Susceptibility]L18855-75-Fluorocytosine [Susceptibility]L408-5Piperacillin [Susceptibility] by Minimum inhibitory concentration (MIC)L18891-2Cefprozil [Susceptibility]L18905-0Cinoxacin [Susceptibility]L41402-9Emtricitabine [Susceptibility] by Genotype methodL30295-0Saquinavir [Susceptibility] by Genotype methodL30297-6Amprenavir [Susceptibility] by Genotype methodL364-0Nitrofurantoin [Susceptibility] by Disk diffusion (KB)L87734-0cefTAZidime+Avibactam [Susceptibility] by Gradient stripL82379-9Daclatasvir [Susceptibility] by Genotype methodL18939-9Lomefloxacin [Susceptibility]L49622-4Tipranavir+Ritonavir [Susceptibility] by Genotype methodL49621-6Saquinavir+Ritonavir [Susceptibility] by Genotype methodL49619-0Indinavir+Ritonavir [Susceptibility] by Genotype methodL49618-2Atazanavir+Ritonavir [Susceptibility] by Genotype methodL73647-0Ceftolozane+Tazobactam [Susceptibility] by Disk diffusion (KB)L82520-8Velpatasvir [Susceptibility] by Genotype methodL49630-7Darunavir+Ritonavir [Susceptibility] by Genotype methodL82377-3Ledipasvir [Susceptibility] by Genotype methodL18894-6Ceftizoxime [Susceptibility]L43736-8Fosamprenavir [Susceptibility] by Genotype methodL82376-5Elbasvir [Susceptibility] by Genotype methodL82378-1Ombitasvir [Susceptibility] by Genotype methodL21-6Amoxicillin+Clavulanate [Susceptibility] by Disk diffusion (KB)L73648-8cefTAZidime+Avibactam [Susceptibility] by Disk diffusion (KB)L45187-2Other Antibiotic [Susceptibility] by Disk diffusion (KB)L18917-5Doxycycline [Susceptibility]L18947-2Mezlocillin [Susceptibility]L77-8ceFAZolin [Susceptibility] by Disk diffusion (KB)L75755-9Methicillin susceptible Staphylococcus aureus DNA [Presence] in Specimen by NAA with probe detectionL18863-1Amphotericin B [Susceptibility]L205-5Colistin [Susceptibility] by Minimum inhibitory concentration (MIC)L1-8Acyclovir [Susceptibility]L517-3Trimethoprim+Sulfamethoxazole [Susceptibility] by Disk diffusion (KB)L57896-3Influenza virus A 2009 H1N1v.neuraminidase inhibitor resistance [Susceptibility] in Specimen by Genotype methodL497-8Tetracycline [Susceptibility] by Disk diffusion (KB)L460-6Streptomycin [Susceptibility] by Minimum inhibitory concentration (MIC)L32603-3Itraconazole [Susceptibility]L55343-8Anidulafungin [Susceptibility] by Minimum inhibitory concentration (MIC)L241-0Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC)L33630-5HIV protease gene mutations detected [Identifier]L33-1Ampicillin+Sulbactam [Susceptibility] by Disk diffusion (KB)L35810-1Fosfomycin [Susceptibility] by Disk diffusion (KB)L31141-5cefTRIAXone [Susceptibility] for meningitis by Gradient stripL73655-3Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype methodL7042-5Penicillin V [Susceptibility] by Gradient stripL82380-7Hepatitis C virus genotype 1 NS5a gene mutations detected [Identifier]L35809-3Fosfomycin [Susceptibility] by Gradient stripL7059-9Vancomycin [Susceptibility] by Gradient stripL57095-2Anidulafungin [Susceptibility]L54176-3Caspofungin [Susceptibility] by Minimum inhibitory concentration (MIC)L42000-0Lopinavir+Ritonavir [Susceptibility] by Genotype methodL41403-7Atazanavir [Susceptibility] by Genotype methodL30294-3Nelfinavir [Susceptibility] by Genotype methodL30292-7Indinavir [Susceptibility] by Genotype methodL30291-9Efavirenz [Susceptibility] by Genotype methodL30289-3Nevirapine [Susceptibility] by Genotype methodL30286-9Stavudine [Susceptibility] by Genotype methodL30284-4Didanosine [Susceptibility] by Genotype methodL30282-8Zidovudine [Susceptibility] by Genotype methodL30287-7Abacavir [Susceptibility] by Genotype methodL18952-2Nalidixate [Susceptibility]L53812-4Micafungin [Susceptibility] by Minimum inhibitory concentration (MIC)L19156-9Susceptibility method [Identifier] in SpecimenL18969-6Piperacillin [Susceptibility]L32378-2Caspofungin [Susceptibility]L6998-9cefTRIAXone [Susceptibility] by Gradient stripL7029-2Meropenem [Susceptibility] by Gradient stripL249-3Fluconazole [Susceptibility] by Minimum inhibitory concentration (MIC)L49573-9HIV genotype [Susceptibility] in Isolate by Genotype method NarrativeL189-1Clarithromycin [Susceptibility] by Minimum inhibitory concentration (MIC)L35863-0Voriconazole [Susceptibility] by Minimum inhibitory concentration (MIC)L18887-0cefoTEtan [Susceptibility]L395-4Penicillin V [Susceptibility] by Minimum lethal concentration (MLC)L41396-3Tenofovir [Susceptibility] by Genotype methodL18873-0Carbenicillin [Susceptibility]L55137-4Penicillin Parenteral [Susceptibility] for meningitis by Minimum inhibitory concentration (MIC)L31140-7cefTRIAXone [Susceptibility] for meningitis by Minimum inhibitory concentration (MIC)L10720-1Terbinafine [Susceptibility] by Minimum inhibitory concentration (MIC)L30283-6lamiVUDine [Susceptibility] by Genotype methodL134-7cefTAZidime [Susceptibility] by Disk diffusion (KB)L24-0Amphotericin B [Susceptibility] by Minimum inhibitory concentration (MIC)L18994-4Ticarcillin [Susceptibility]L18959-7Ofloxacin [Susceptibility]L84-4Cefaclor [Susceptibility] by Minimum inhibitory concentration (MIC)L18935-7Kanamycin [Susceptibility]L80689-3HIV 1 RNA reverse transcriptase and protease and integrase gene mutations detected [Identifier] in Plasma by SequencingL35783-0Cefuroxime Oral [Susceptibility]L31138-1Cefotaxime [Susceptibility] for meningitis by Minimum inhibitory concentration (MIC)L29-9Ampicillin [Susceptibility] by Disk diffusion (KB)L509-0Tobramycin [Susceptibility] by Disk diffusion (KB)L18866-4Azithromycin [Susceptibility]L13-3Amikacin [Susceptibility] by Disk diffusion (KB)L62261-3Vancomycin resistance vanA + vanB genes [Presence] by Molecular methodL32379-0Voriconazole [Susceptibility]L18956-3Norfloxacin [Susceptibility]L20462-8Streptomycin [Susceptibility] by Method for Slow-growing mycobacteriaL30554-0HIV reverse transcriptase gene mutations detected [Identifier]L108-1Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC)L6985-6Beta lactamase.usual [Susceptibility]L53798-5HIV reverse transcriptase+protease gene mutations detected [Identifier]L48558-1HIV genotype [Susceptibility]L86712-7Carbapenem resistance blaOXA gene [Presence] by Molecular methodL85501-5Carbapenem resistance blaVIM gene [Presence] by Molecular methodL73982-1Carbapenem resistance blaNDM gene [Presence] by Molecular methodL85498-4Carbapenem resistance blaIMP gene [Presence] by Molecular methodL88250-6Cephalosporin resistance blaCTX-M gene [Presence] by Molecular methodL18995-1Ticarcillin+Clavulanate [Susceptibility]L18900-1Cephalothin [Susceptibility]L392-1Penicillin G [Susceptibility] by Minimum inhibitory concentration (MIC)L18997-7Trimethoprim [Susceptibility]L234-5Erythromycin [Susceptibility] by Disk diffusion (KB)L18896-1Cefuroxime Parenteral [Susceptibility]L194-1Clindamycin [Susceptibility] by Disk diffusion (KB)L142-0cefTRIAXone [Susceptibility] by Disk diffusion (KB)L525-6Vancomycin [Susceptibility] by Disk diffusion (KB)L7041-7Penicillin G [Susceptibility] by Gradient stripL18924-1Fluconazole [Susceptibility]L72421-1Vancomycin resistance vanB gene [Presence] by Molecular methodL48814-8Vancomycin resistance vanA gene [Presence] by Molecular methodL36-4Azithromycin [Susceptibility] by Minimum inhibitory concentration (MIC)L366-5Norfloxacin [Susceptibility] by Minimum lethal concentration (MLC)L173-5Chloramphenicol [Susceptibility] by Minimum inhibitory concentration (MIC)L48813-0Methicillin resistance mecA gene [Presence] by Molecular methodL18890-4Cefpodoxime [Susceptibility]L18903-5Chloramphenicol [Susceptibility]L23640-6Quinupristin+Dalfopristin [Susceptibility]L35789-7DAPTOmycin [Susceptibility]L29258-1Linezolid [Susceptibility]L18974-6rifAMPin [Susceptibility]L8272-7Cefepime [Susceptibility] by Disk diffusion (KB)L6653-0Meropenem [Susceptibility] by Disk diffusion (KB)L413-5Piperacillin+Tazobactam [Susceptibility] by Disk diffusion (KB)L268-3Gentamicin [Susceptibility] by Disk diffusion (KB)L186-7Ciprofloxacin [Susceptibility] by Disk diffusion (KB)L45-5Aztreonam [Susceptibility] by Disk diffusion (KB)L21367-8levoFLOXacin [Susceptibility] by Disk diffusion (KB)L18964-7Penicillin [Susceptibility]L18961-3Oxacillin [Susceptibility]L18919-1Erythromycin [Susceptibility]L18908-4Clindamycin [Susceptibility]L6984-9Beta lactamase.extended spectrum [Susceptibility]L31039-1Moxifloxacin [Susceptibility]L56031-8Doripenem [Susceptibility] by Minimum inhibitory concentration (MIC)L19000-9Vancomycin [Susceptibility]L72891-5Staphylococcus protein A spa gene [Presence] in Isolate or Specimen by NAA with probe detectionL73627-2Ceftaroline [Susceptibility] by Minimum inhibitory concentration (MIC)L72887-3Staphylococcus aureus methicillin resistance SCCmec [Presence] in Nose by NAA with probe detectionL60535-2Doripenem [Susceptibility]L6933-6Streptomycin [Susceptibility] by MIC.High potencyL7018-5Gentamicin [Susceptibility] by MIC.High potencyL25596-8Fosfomycin [Susceptibility]L18868-0Aztreonam [Susceptibility]L18888-8cefOXitin [Susceptibility]L23641-4Quinupristin+Dalfopristin [Susceptibility] by Minimum inhibitory concentration (MIC)L42357-4Tigecycline [Susceptibility]L335-0Minocycline [Susceptibility] by Minimum inhibitory concentration (MIC)L31037-5Moxifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)L18932-4Imipenem [Susceptibility]L51724-3Cefuroxime [Susceptibility]L18886-2Cefotaxime [Susceptibility]L18860-7Amikacin [Susceptibility]L49617-4Carbapenem resistance blaKPC gene [Presence] by Molecular methodL18862-3Amoxicillin+Clavulanate [Susceptibility]L35802-8Ertapenem [Susceptibility]L18943-1Meropenem [Susceptibility]L21070-8Other Antibiotic [Susceptibility] by Minimum inhibitory concentration (MIC)L225-3Doxycycline [Susceptibility] by Minimum inhibitory concentration (MIC)L18983-7Streptomycin [Susceptibility] by High potencyL6932-8Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)L18993-6Tetracycline [Susceptibility]L18970-4Piperacillin+Tazobactam [Susceptibility]L18865-6Ampicillin+Sulbactam [Susceptibility]L18996-9Tobramycin [Susceptibility]L18879-7Cefepime [Susceptibility]L504-1Ticarcillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)L18955-5Nitrofurantoin [Susceptibility]L18878-9ceFAZolin [Susceptibility]L18895-3cefTRIAXone [Susceptibility]L18864-9Ampicillin [Susceptibility]L29254-0Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)L18928-2Gentamicin [Susceptibility]L20629-2levoFLOXacin [Susceptibility]L18906-8Ciprofloxacin [Susceptibility]L18893-8cefTAZidime [Susceptibility]L116-4cefOXitin [Susceptibility] by Minimum inhibitory concentration (MIC)L18998-5Trimethoprim+Sulfamethoxazole [Susceptibility]L18929-0Gentamicin [Susceptibility] by High potencyL428-3rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)L133-9cefTAZidime [Susceptibility] by Minimum inhibitory concentration (MIC)L35788-9DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)L20-8Amoxicillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)L193-3Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)L233-7Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)L383-0Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)L35801-0Ertapenem [Susceptibility] by Minimum inhibitory concentration (MIC)L51774-8Cefuroxime [Susceptibility] by Minimum inhibitory concentration (MIC)L41659-4ABT492 [Susceptibility] by Disk diffusion (KB)L44-8Aztreonam [Susceptibility] by Minimum inhibitory concentration (MIC)L18948-0Minocycline [Susceptibility]L524-9Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)L42355-8Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)L279-0Imipenem [Susceptibility] by Minimum inhibitory concentration (MIC)L12-5Amikacin [Susceptibility] by Minimum inhibitory concentration (MIC)L6652-2Meropenem [Susceptibility] by Minimum inhibitory concentration (MIC)L20396-8levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)L496-0Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)L32-3Ampicillin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC)L6644-9Cefepime [Susceptibility] by Minimum inhibitory concentration (MIC)L61188-9Clindamycin [Susceptibility] by Erythromycin induced resistanceL363-2Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)L76-0ceFAZolin [Susceptibility] by Minimum inhibitory concentration (MIC)L412-7Piperacillin+Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC)L28-1Ampicillin [Susceptibility] by Minimum inhibitory concentration (MIC)L508-2Tobramycin [Susceptibility] by Minimum inhibitory concentration (MIC)L141-2cefTRIAXone [Susceptibility] by Minimum inhibitory concentration (MIC)L23658-8Other Antibiotic [Susceptibility]L185-9Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)L267-5Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)L516-5Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)L35492-8Methicillin resistant Staphylococcus aureus (MRSA) DNA [Presence] in Specimen by NAA with probe detectionL10-9Amdinocillin [Susceptibility] by Serum bactericidal titerL100041-3Aminoglycoside [Susceptibility]L100042-1Atovaquone [Susceptibility]L100043-9Azithromycin+Ethambutol [Susceptibility]L100044-7Cefcapene [Susceptibility]L100045-4Cefozopran [Susceptibility]L100046-2Cefquinome [Susceptibility]L100047-0Cefteram [Susceptibility]L100048-8Clarithromycin+Ethambutol [Susceptibility]L100049-6Eravacycline [Susceptibility]L100050-4Erythromycin+Ethambutol [Susceptibility]L100051-2Ethambutol+rifAMPin [Susceptibility]L100052-0Flomoxef [Susceptibility]L100053-8Fluoroquinolone [Susceptibility]L100054-6Gamithromycin [Susceptibility]L100055-3Optochin [Susceptibility]L100056-1Panipenem [Susceptibility]L100057-9Prothionamide [Susceptibility]L100058-7Prulifloxacin [Susceptibility]L100059-5Rifapentine [Susceptibility]L100060-3Tildipirosin [Susceptibility]L100061-1Tosufloxacin [Susceptibility]L100699-8Rifabutin+Ethambutol [Susceptibility]L100983-6HIV reverse transcriptase failed codons [Identifier] by Genotype methodL100984-4HIV 1 group M RNA genotype [Identifier] by Genotype methodL100985-1HIV protease failed codons [Identifier] by Genotype methodL100986-9HIV integrase failed codons [Identifier] by Genotype methodL101123-8Bacterial carbapenem resistance blaIMI gene [Presence] by Molecular methodL101124-6Bacterial carbapenem resistance blaIMI+blaNMC genes [Presence] by Molecular methodL101125-3Bacterial carbapenem resistance blaOXA-235-like gene [Presence] by Molecular methodL101126-1Bacterial carbapenem resistance blaOXA-24+blaOXA-40 gene [Presence] by Molecular methodL101127-9Bacterial carbapenem resistance blaSIM gene [Presence] by Molecular methodL101222-8Meropenem+Vaborbactam [Susceptibility] by Disk diffusion (KB)L101477-8Ampicillin [Susceptibility] by MIC.VOC detection in Positive blood cultureL101478-6Ampicillin+Sulbactam [Susceptibility] by MIC.VOC detection in Positive blood cultureL101479-4Cefotaxime [Susceptibility] by MIC.VOC detection in Positive blood cultureL101480-2Cefotaxime+Clavulanate [Susceptibility] by MIC.VOC detection in Positive blood cultureL101481-0cefTAZidime [Susceptibility] by MIC.VOC detection in Positive blood cultureL101482-8cefTAZidime+Clavulanate [Susceptibility] by MIC.VOC detection in Positive blood cultureL101483-6cefTAZidime+Avibactam [Susceptibility] by MIC.VOC detection in Positive blood cultureL101484-4Ceftolozane+Tazobactam [Susceptibility] by MIC.VOC detection in Positive blood cultureL101485-1cefTRIAXone [Susceptibility] by MIC.VOC detection in Positive blood cultureL101486-9Ertapenem [Susceptibility] by MIC.VOC detection in Positive blood cultureL101487-7Imipenem [Susceptibility] by MIC.VOC detection in Positive blood cultureL101488-5Meropenem [Susceptibility] by MIC.VOC detection in Positive blood cultureL101489-3Meropenem+Vaborbactam [Susceptibility] by MIC.VOC detection in Positive blood cultureL101490-1Piperacillin [Susceptibility] by MIC.VOC detection in Positive blood cultureL101491-9Piperacillin+Tazobactam [Susceptibility] by MIC.VOC detection in Positive blood cultureL101492-7cefOXitin [Susceptibility] by MIC.VOC detection in Positive blood cultureL101493-5Amikacin [Susceptibility] by MIC.VOC detection in Positive blood cultureL101494-3Gentamicin [Susceptibility] by MIC.VOC detection in Positive blood cultureL101495-0Trimethoprim+Sulfamethoxazole [Susceptibility] by MIC.VOC detection in Positive blood cultureL101496-8Tobramycin [Susceptibility] by MIC.VOC detection in Positive blood cultureL101497-6Aztreonam [Susceptibility] by MIC.VOC detection in Positive blood cultureL101498-4Amoxicillin+Clavulanate [Susceptibility] by MIC.VOC detection in Positive blood cultureL101499-2Tigecycline [Susceptibility] by MIC.VOC detection in Positive blood cultureL101500-7Ciprofloxacin [Susceptibility] by MIC.VOC detection in Positive blood cultureL101501-5levoFLOXacin [Susceptibility] by MIC.VOC detection in Positive blood cultureL101502-3Cefepime [Susceptibility] by MIC.VOC detection in Positive blood cultureL101503-1Cefuroxime [Susceptibility] by MIC.VOC detection in Positive blood cultureL101504-9Tetracycline [Susceptibility] by MIC.VOC detection in Positive blood cultureL101525-4Valnemulin [Susceptibility] by Minimum inhibitory concentration (MIC)L101526-2Tylvalosin [Susceptibility] by Minimum inhibitory concentration (MIC)L101576-7Bacterial gyrB gene drug resistance mutation [Identifier] by Molecular methodL101583-3ESBL by ceftazidime to ceftazidime-clavulanate IC ratio [Interpretation] by based on lab data in Positive blood culture QualitativeL102-4Cefoperazone [Susceptibility] by Serum bactericidal titerL103-2Ceforanide [Susceptibility] by Minimum lethal concentration (MLC)L103608-6Sulbactam+Durlobactam [Susceptibility] by Gradient stripL103653-2Ciprofloxacin [Susceptibility] for meningitisL103654-0Meropenem [Susceptibility] for meningitisL103672-2Amoxicillin+Clavulanate [Susceptibility] for UTIL103788-6Bacteria Identification and Susceptibility in Positive blood culture DocumentL103958-5Ofloxacin [Susceptibility] by Genotype methodL103959-3cycloSERINE [Susceptibility] by Genotype methodL103960-1Prothionamide [Susceptibility] by Genotype methodL104-0Ceforanide [Susceptibility] by Minimum inhibitory concentration (MIC)L104691-1Clofazimine+Amikacin [Susceptibility] by Minimum inhibitory concentration (MIC)L104864-4Beta lactamase.extended spectrum [Presence]L105-7Ceforanide [Susceptibility] by Disk diffusion (KB)L105013-7Bacterial carbapenem resistance blaGES-11 gene [Presence] by Molecular methodL105014-5Bacterial Carbapenem resistance blaGES-5 gene [Presence] by Molecular methodL105015-2Bacterial Carbapenem resistance blaGIM-1 gene [Presence] by Molecular methodL105016-0Bacterial Carbapenem resistance blaKPC-18 gene [Presence] by Molecular methodL105017-8Bacterial Carbapenem resistance blaKPC-2 gene [Presence] by Molecular methodL105018-6Bacterial Carbapenem resistance blaKPC-3 gene [Presence] by Molecular methodL105019-4Bacterial Carbapenem resistance blaNDM-1 gene [Presence] by Molecular methodL105020-2Bacterial Carbapenem resistance blaNDM-19 gene [Presence] by Molecular methodL105021-0Bacterial Carbapenem resistance blaNDM-4 gene [Presence] by Molecular methodL105022-8Bacterial Carbapenem resistance blaNDM-5 gene [Presence] by Molecular methodL105023-6Bacterial Carbapenem resistance blaNDM-7 gene [Presence] by Molecular methodL105024-4Bacterial Carbapenem resistance blaNDM-9 gene [Presence] by Molecular methodL105025-1Bacterial Carbapenem resistance blaOXA 181 gene [Presence] by Molecular methodL105026-9Bacterial Carbapenem resistance blaOXA-162 gene [Presence] by Molecular methodL105027-7Bacterial Carbapenem resistance blaOXA-23 gene [Presence] by Molecular methodL105028-5Bacterial Carbapenem resistance blaOXA-232 gene [Presence] by Molecular methodL105029-3Bacterial Carbapenem resistance blaOXA24/40 gene [Presence] by Molecular methodL105030-1Bacterial Carbapenem resistance blaOXA-244 gene [Presence] by Molecular methodL105031-9Bacterial Carbapenem resistance blaOXA-58 gene [Presence] by Molecular methodL105032-7Bacterial Carbapenem resistance blaOXA-72 gene [Presence] by Molecular methodL105033-5Bacterial Carbapenem resistance ISAba1 upstream blaOXA-51 gene [Presence] by Molecular methodL105034-3Bacterial Carbapenem resistance blaVIM-1 gene [Presence] by Molecular methodL105035-0Bacterial Carbapenem resistance blaVIM-2 gene [Presence] by Molecular methodL105036-8Bacterial Carbapenem resistance blaVIM-4 gene [Presence] by Molecular methodL105037-6OXA-23 carbapenemase [Presence] by Rapid immunoassayL105038-4OXA-40 and OXA-58 carbapenemase [Presence] by Rapid immunoassayL105179-6Aztreonam+Avibactam [Susceptibility] by Gradient stripL105268-7Clindamycin [Susceptibility] by MIC.erythromycin induced resistanceL105777-7Aminoglycoside 6'-N-acetyltransferase type Ib gene [Cycle Threshold #] in Positive blood culture by NAA with probe detectionL105778-5Bacterial beta-lactam resistance AmpC blaCMY+blaLAT+blaDHA+blaFOX gene [Cycle Threshold #] in Positive blood culture by NAA with probe detectionL105779-3Bacterial aminoglycoside resistance ArmA gene [Cycle Threshold #] in Positive blood culture by NAA with probe detectionL105780-1Cephalosporin resistance blaCTX-M gene [Cycle Threshold #] in Positive blood culture by NAA with probe detectionL105781-9Bacterial beta-lactam resistance blaGES gene [Cycle Threshold #] in Positive blood culture by NAA with probe detectionL105782-7Bacterial beta-lactam resistance blaIMP gene [Cycle Threshold #] in Positive blood culture by NAA with probe detectionL105783-5Bacterial beta-lactam resistance blaKPC gene [Cycle Threshold #] in Positive blood culture by NAA with probe detectionL105784-3Bacterial beta-lactam resistance blaNDM gene [Cycle Threshold #] in Positive blood culture by NAA with probe detectionL106-5Ceforanide [Susceptibility] by Serum bactericidal titerL106432-8cefTAZidime+cloxacillin [Susceptibility] by Disk diffusion (KB)L106433-6cefOXitin [Susceptibility] QualitativeL106434-4Aztreonam+Avibactam [Susceptibility] by Minimum inhibitory concentration (MIC)L106435-1Beta lactamase.AmpC type [Susceptibility]L10654-2Clotrimazole [Susceptibility] by Minimum lethal concentration (MLC)L106742-0Letermovir [Susceptibility] by Genotype methodL106858-4Rezafungin [Susceptibility]L106859-2Sulbactam+Durlobactam [Susceptibility]L106861-8Cytomegalovirus UL56 gene mutations detected [Identifier]L10697-1Nystatin [Susceptibility] by Minimum inhibitory concentration (MIC)L107-3Cefotaxime [Susceptibility] by Minimum lethal concentration (MLC)L107195-0Aztreonam+Avibactam [Susceptibility] by Disk diffusion (KB)L10721-9Terbinafine [Susceptibility] by Minimum lethal concentration (MLC)L107337-8Amikacin [Susceptibility] liposome inhaled breakpoints by Minimum inhibitory concentration (MIC)L11-7Amikacin [Susceptibility] by Minimum lethal concentration (MLC)L110-7Cefotaxime [Susceptibility] by Serum bactericidal titerL111-5cefoTEtan [Susceptibility] by Minimum lethal concentration (MLC)L114-9cefoTEtan [Susceptibility] by Serum bactericidal titerL115-6cefOXitin [Susceptibility] by Minimum lethal concentration (MLC)L11575-8Cefmetazole [Susceptibility] by Gradient stripL11576-6Erythromycin+Sulfisoxazole [Susceptibility] by Gradient stripL11577-4Sulfamethoxazole [Susceptibility] by Gradient stripL11578-2sulfiSOXAZOLE [Susceptibility] by Gradient stripL118-0cefOXitin [Susceptibility] by Serum bactericidal titerL119-8Cefpodoxime [Susceptibility] by Minimum lethal concentration (MLC)L121-4Cefpodoxime [Susceptibility] by Disk diffusion (KB)L122-2Cefpodoxime [Susceptibility] by Serum bactericidal titerL123-0Cefprozil [Susceptibility] by Minimum lethal concentration (MLC)L124-8Cefprozil [Susceptibility] by Minimum inhibitory concentration (MIC)L125-5Cefprozil [Susceptibility] by Disk diffusion (KB)L126-3Cefprozil [Susceptibility] by Serum bactericidal titerL127-1Cefsulodin [Susceptibility] by Minimum lethal concentration (MLC)L128-9Cefsulodin [Susceptibility] by Minimum inhibitory concentration (MIC)L129-7Cefsulodin [Susceptibility] by Disk diffusion (KB)L130-5Cefsulodin [Susceptibility] by Serum bactericidal titerL132-1cefTAZidime [Susceptibility] by Minimum lethal concentration (MLC)L135-4cefTAZidime [Susceptibility] by Serum bactericidal titerL136-2Ceftizoxime [Susceptibility] by Minimum lethal concentration (MLC)L139-6Ceftizoxime [Susceptibility] by Serum bactericidal titerL14-1Amikacin [Susceptibility] by Serum bactericidal titerL140-4cefTRIAXone [Susceptibility] by Minimum lethal concentration (MLC)L143-8cefTRIAXone [Susceptibility] by Serum bactericidal titerL14332-1Para aminosalicylate [Susceptibility] by Minimum inhibitory concentration (MIC)L144-6Cefuroxime Parenteral [Susceptibility] by Minimum lethal concentration (MLC)L147-9Cefuroxime Parenteral [Susceptibility] by Serum bactericidal titerL148-7Cephalexin [Susceptibility] by Minimum lethal concentration (MLC)L149-5Cephalexin [Susceptibility] by Minimum inhibitory concentration (MIC)L15-8Amoxicillin [Susceptibility] by Minimum lethal concentration (MLC)L150-3Cephalexin [Susceptibility] by Disk diffusion (KB)L151-1Cephalexin [Susceptibility] by Serum bactericidal titerL152-9Cephaloglycin [Susceptibility] by Minimum lethal concentration (MLC)L153-7Cephaloglycin [Susceptibility] by Minimum inhibitory concentration (MIC)L15336-1Other Antibiotic [Susceptibility] by Serum bactericidal titerL15337-9Other Antibiotic [Susceptibility] by Serum bactericidal titer --peakL15338-7Other Antibiotic [Susceptibility] by Serum bactericidal titer --troughL154-5Cephaloglycin [Susceptibility] by Disk diffusion (KB)L155-2Cephaloglycin [Susceptibility] by Serum bactericidal titerL156-0Cephaloridine [Susceptibility] by Minimum lethal concentration (MLC)L157-8Cephaloridine [Susceptibility] by Minimum inhibitory concentration (MIC)L158-6Cephaloridine [Susceptibility] by Disk diffusion (KB)L159-4Cephaloridine [Susceptibility] by Serum bactericidal titerL160-2Cephalothin [Susceptibility] by Minimum lethal concentration (MLC)L163-6Cephalothin [Susceptibility] by Serum bactericidal titerL16320-4Acyclovir [Susceptibility] by Serum bactericidal titerL16350-1Amantadine [Susceptibility] by Serum bactericidal titerL16387-3Rifabutin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC)L164-4Cephapirin [Susceptibility] by Minimum lethal concentration (MLC)L16421-0Azithromycin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC)L165-1Cephapirin [Susceptibility] by Minimum inhibitory concentration (MIC)L166-9Cephapirin [Susceptibility] by Disk diffusion (KB)L16620-7Clarithromycin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC)L167-7Cephapirin [Susceptibility] by Serum bactericidal titerL168-5Cephradine [Susceptibility] by Minimum lethal concentration (MLC)L16830-2Erythromycin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC)L16841-9Ethambutol+rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)L169-3Cephradine [Susceptibility] by Minimum inhibitory concentration (MIC)L170-1Cephradine [Susceptibility] by Disk diffusion (KB)L171-9Cephradine [Susceptibility] by Serum bactericidal titerL172-7Chloramphenicol [Susceptibility] by Minimum lethal concentration (MLC)L175-0Chloramphenicol [Susceptibility] by Serum bactericidal titerL176-8Chlortetracycline [Susceptibility] by Minimum lethal concentration (MLC)L177-6Chlortetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)L178-4Chlortetracycline [Susceptibility] by Disk diffusion (KB)L179-2Chlortetracycline [Susceptibility] by Serum bactericidal titerL18-2Amoxicillin [Susceptibility] by Serum bactericidal titerL180-0Cinoxacin [Susceptibility] by Minimum lethal concentration (MLC)L183-4Cinoxacin [Susceptibility] by Serum bactericidal titerL184-2Ciprofloxacin [Susceptibility] by Minimum lethal concentration (MLC)L187-5Ciprofloxacin [Susceptibility] by Serum bactericidal titerL188-3Clarithromycin [Susceptibility] by Minimum lethal concentration (MLC)L18857-3Almecillin [Susceptibility]L18859-9Amdinocillin [Susceptibility]L18867-2Azlocillin [Susceptibility]L18869-8Bacampicillin [Susceptibility]L18870-6Bacitracin [Susceptibility]L18871-4Butirosin [Susceptibility]L18872-2Capreomycin [Susceptibility]L18875-5Cefadroxil [Susceptibility]L18876-3Cefamandole [Susceptibility]L18877-1Cefatrizine [Susceptibility]L18882-1Cefodizime [Susceptibility]L18885-4Ceforanide [Susceptibility]L18889-6Cefpirome [Susceptibility]L18892-0Cefsulodin [Susceptibility]L18897-9Cephalexin [Susceptibility]L18898-7Cephaloglycin [Susceptibility]L18899-5Cephaloridine [Susceptibility]L18901-9Cephapirin [Susceptibility]L18902-7Cephradine [Susceptibility]L18904-3Chlortetracycline [Susceptibility]L18909-2Clotrimazole [Susceptibility]L18910-0Cloxacillin [Susceptibility]L18911-8ColistimethateL18913-4Cyclacillin [Susceptibility]L18914-2cycloSERINE [Susceptibility]L18915-9Demeclocycline [Susceptibility]L18923-3Floxacillin [Susceptibility]L18926-6Framycetin [Susceptibility]L18927-4Fusidate [Susceptibility]L18930-8Gramicidin D [Susceptibility]L18931-6Hetacillin [Susceptibility]L18936-5Kanamycin [Susceptibility] by High potencyL18937-3Ketoconazole [Susceptibility]L18938-1Lincomycin [Susceptibility]L18940-7Loracarbef [Susceptibility]L18941-5Lymecycline [Susceptibility]L18942-3Meclocycline [Susceptibility]L18944-9Methacycline [Susceptibility]L18945-6Methicillin [Susceptibility]L18949-8Miocamycin [Susceptibility]L18951-4Nafcillin [Susceptibility]L18954-8Netilmicin [Susceptibility]L18957-1Novobiocin [Susceptibility]L18958-9Nystatin [Susceptibility]L18960-5Oleandomycin [Susceptibility]L18962-1Oxytetracycline [Susceptibility]L18963-9Pefloxacin [Susceptibility]L18967-0Phenethicillin [Susceptibility]L18968-8Pipemidate [Susceptibility]L18971-2Pivampicillin [Susceptibility]L18975-3Ristocetin [Susceptibility]L18976-1Rolitetracycline [Susceptibility]L18977-9Rosoxacin [Susceptibility]L18978-7Roxithromycin [Susceptibility]L18979-5Sisomicin [Susceptibility]L18981-1Spiramycin [Susceptibility]L18984-5sulfADIAZINE [Susceptibility]L18985-2Sulfamethoxazole [Susceptibility]L18987-8Sulfonamide [Susceptibility]L18988-6Talampicillin [Susceptibility]L18989-4Teicoplanin [Susceptibility]L18990-2Temafloxacin [Susceptibility]L18991-0Temocillin [Susceptibility]L18992-8Terbinafine [Susceptibility]L18999-3Troleandomycin [Susceptibility]L19-0Amoxicillin+Clavulanate [Susceptibility] by Minimum lethal concentration (MLC)L19001-7Viomycin [Susceptibility]L191-7Clarithromycin [Susceptibility] by Serum bactericidal titerL192-5Clindamycin [Susceptibility] by Minimum lethal concentration (MLC)L195-8Clindamycin [Susceptibility] by Serum bactericidal titerL196-6Cloxacillin [Susceptibility] by Minimum lethal concentration (MLC)L197-4Cloxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)L198-2Cloxacillin [Susceptibility] by Disk diffusion (KB)L199-0Cloxacillin [Susceptibility] by Serum bactericidal titerL2-6Almecillin [Susceptibility] by Minimum lethal concentration (MLC)L200-6Colistimethate by Minimum lethal concentration (MLC)L202-2Colistimethate by Disk diffusion (KB)L203-0Colistimethate [Susceptibility] by Serum bactericidal titerL20374-5Ampicillin+Sulbactam [Susceptibility] by Method for Slow-growing mycobacteriaL20376-0Clofazimine [Susceptibility] by Method for Slow-growing mycobacteriaL20378-6Ceftizoxime [Susceptibility] by Method for Slow-growing mycobacteriaL20379-4Doxycycline [Susceptibility] by Method for Slow-growing mycobacteriaL20380-2Erythromycin [Susceptibility] by Method for Slow-growing mycobacteriaL20381-0Ethambutol [Susceptibility] by Method for Slow-growing mycobacteriaL20382-8Ethionamide [Susceptibility] by Method for Slow-growing mycobacteriaL20383-6Isoniazid [Susceptibility] by Method for Slow-growing mycobacteriaL20384-4Ofloxacin [Susceptibility] by Method for Slow-growing mycobacteriaL20385-1rifAMPin [Susceptibility] by Method for Slow-growing mycobacteriaL20386-9Rifabutin [Susceptibility] by Method for Slow-growing mycobacteriaL20388-5Nitrofurazone [Susceptibility]L20389-3Mupirocin [Susceptibility]L20391-9Mafenide [Susceptibility]L20397-6Sparfloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)L204-8Colistin [Susceptibility] by Minimum lethal concentration (MLC)L207-1Colistin [Susceptibility] by Serum bactericidal titerL208-9Cyclacillin [Susceptibility] by Minimum lethal concentration (MLC)L209-7Cyclacillin [Susceptibility] by Minimum inhibitory concentration (MIC)L210-5Cyclacillin [Susceptibility] by Disk diffusion (KB)L211-3Cyclacillin [Susceptibility] by Serum bactericidal titerL212-1cycloSERINE [Susceptibility] by Minimum lethal concentration (MLC)L213-9cycloSERINE [Susceptibility] by Minimum inhibitory concentration (MIC)L21316-5Grepafloxacin [Susceptibility] by Gradient stripL214-7cycloSERINE [Susceptibility] by Disk diffusion (KB)L215-4cycloSERINE [Susceptibility] by Serum bactericidal titerL216-2Demeclocycline [Susceptibility] by Minimum lethal concentration (MLC)L217-0Demeclocycline [Susceptibility] by Minimum inhibitory concentration (MIC)L218-8Demeclocycline [Susceptibility] by Disk diffusion (KB)L219-6Demeclocycline [Susceptibility] by Serum bactericidal titerL22-4Amoxicillin+Clavulanate [Susceptibility] by Serum bactericidal titerL220-4Dicloxacillin [Susceptibility] by Minimum lethal concentration (MLC)L221-2Dicloxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)L222-0Dicloxacillin [Susceptibility] by Disk diffusion (KB)L223-8Dicloxacillin [Susceptibility] by Serum bactericidal titerL224-6Doxycycline [Susceptibility] by Minimum lethal concentration (MLC)L227-9Doxycycline [Susceptibility] by Serum bactericidal titerL228-7Enoxacin [Susceptibility] by Minimum lethal concentration (MLC)L229-5Enoxacin [Susceptibility] by Minimum inhibitory concentration (MIC)L23-2Amphotericin B [Susceptibility] by Minimum lethal concentration (MLC)L230-3Enoxacin [Susceptibility] by Disk diffusion (KB)L231-1Enoxacin [Susceptibility] by Serum bactericidal titerL232-9Erythromycin [Susceptibility] by Minimum lethal concentration (MLC)L235-2Erythromycin [Susceptibility] by Serum bactericidal titerL236-0Erythromycin+Sulfisoxazole [Susceptibility] by Minimum lethal concentration (MLC)L23609-1Kanamycin [Susceptibility] by Method for Slow-growing mycobacteriaL23610-9Sparfloxacin [Susceptibility] by Method for Slow-growing mycobacteriaL23612-5Azithromycin [Susceptibility] by Method for Slow-growing mycobacteriaL23614-1Trimethoprim [Susceptibility] by Method for Slow-growing mycobacteriaL23615-8Vancomycin [Susceptibility] by Method for Slow-growing mycobacteriaL23616-6Viomycin [Susceptibility] by Method for Slow-growing mycobacteriaL23627-3Clofazimine [Susceptibility]L23628-1Sparfloxacin [Susceptibility]L23629-9Para aminosalicylate [Susceptibility]L23636-4Cefdinir [Susceptibility]L23637-2Cefdinir [Susceptibility] by Minimum inhibitory concentration (MIC)L23639-8Grepafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)L23643-0Trovafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)L23659-6Apramycin [Susceptibility]L237-8Erythromycin+Sulfisoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)L23709-9Ceftiofur [Susceptibility]L23712-3Enrofloxacin [Susceptibility]L23740-4Florfenicol [Susceptibility]L238-6Erythromycin+Sulfisoxazole [Susceptibility] by Disk diffusion (KB)L239-4Erythromycin+Sulfisoxazole [Susceptibility] by Serum bactericidal titerL240-2Ethambutol [Susceptibility] by Minimum lethal concentration (MLC)L242-8Ethambutol [Susceptibility] by Disk diffusion (KB)L243-6Ethambutol [Susceptibility] by Serum bactericidal titerL244-4Floxacillin [Susceptibility] by Minimum lethal concentration (MLC)L245-1Floxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)L246-9Floxacillin [Susceptibility] by Disk diffusion (KB)L247-7Floxacillin [Susceptibility] by Serum bactericidal titerL248-5Fluconazole [Susceptibility] by Minimum lethal concentration (MLC)L25-7Amphotericin B [Susceptibility] by Disk diffusion (KB)L250-1Fluconazole [Susceptibility] by Disk diffusion (KB)L251-9Fluconazole [Susceptibility] by Serum bactericidal titerL25177-7Amikacin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 12.0 ug/mLL25178-5Amikacin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 30.0 ug/mLL25183-5Ethionamide [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 11.0 ug/mLL25184-3rifAMPin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 14.0 ug/mLL25189-2Ciprofloxacin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 5.0 ug/mLL252-75-Fluorocytosine [Susceptibility] by Minimum lethal concentration (MLC)L25207-2cycloSERINE [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 10.0 ug/mLL25208-0cycloSERINE [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 20.0 ug/mL25211-4Capreomycin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 20.0 ug/mL25212-2Capreomycin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 30.0 ug/mLL25213-0Kanamycin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 6.0 ug/mLL25214-8Kanamycin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 30.0 ug/mLL25215-5Para aminosalicylate [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 2.0 ug/mLL25216-3Para aminosalicylate [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 8.0 ug/mLL25220-5cefOXitin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 30.0 ug/mLL25221-3Imipenem [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 10.0 ug/mLL25222-1Cefmetazole [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 30.0 ug/mLL25223-9Doxycycline [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 30.0 ug/mLL25224-7Erythromycin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 15.0 ug/mLL25225-4Minocycline [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 30.0 ug/mLL25226-2sulfiSOXAZOLE [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 300.0 ug/mLL25227-0Tobramycin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 10.0 ug/mLL25228-8Vancomycin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 30.0 ug/mLL25310-4Amoxicillin+Clavulanate [Susceptibility] by Method for Slow-growing mycobacteriaL25367-4cefTRIAXone [Susceptibility] by Method for Slow-growing mycobacteriaL254-35-Fluorocytosine [Susceptibility] by Disk diffusion (KB)L25411-0Fleroxacin [Susceptibility] by Minimum inhibitory concentration (MIC)L255-05-Fluorocytosine [Susceptibility] by Serum bactericidal titerL25595-0Econazole [Susceptibility]L25597-6Josamycine [Susceptibility]L25607-3Miconazole [Susceptibility]L25608-1Nitroxoline [Susceptibility]L25637-0Econazole [Susceptibility] by Minimum inhibitory concentration (MIC)L257-6Framycetin [Susceptibility] by Minimum lethal concentration (MLC)L25702-2Josamycine [Susceptibility] by Minimum inhibitory concentration (MIC)L25722-0Miconazole [Susceptibility] by Minimum inhibitory concentration (MIC)L25723-8Nitroxoline [Susceptibility] by Minimum inhibitory concentration (MIC)L258-4Framycetin [Susceptibility] by Minimum inhibitory concentration (MIC)L259-2Framycetin [Susceptibility] by Disk diffusion (KB)L26-5Amphotericin B [Susceptibility] by Serum bactericidal titerL260-0Framycetin [Susceptibility] by Serum bactericidal titerL261-8Fusidate [Susceptibility] by Minimum lethal concentration (MLC)L262-6Fusidate [Susceptibility] by Minimum inhibitory concentration (MIC)L263-4Fusidate [Susceptibility] by Disk diffusion (KB)L264-2Fusidate [Susceptibility] by Serum bactericidal titerL265-9Ganciclovir [Susceptibility]L269-1Gentamicin [Susceptibility] by Serum bactericidal titerL27-3Ampicillin [Susceptibility] by Minimum lethal concentration (MLC)L270-9Gramicidin D [Susceptibility] by Minimum lethal concentration (MLC)L271-7Gramicidin D [Susceptibility] by Minimum inhibitory concentration (MIC)L272-5Gramicidin D [Susceptibility] by Disk diffusion (KB)L273-3Gramicidin D [Susceptibility] by Serum bactericidal titerL274-1Hetacillin [Susceptibility] by Minimum lethal concentration (MLC)L275-8Hetacillin [Susceptibility] by Minimum inhibitory concentration (MIC)L276-6Hetacillin [Susceptibility] by Disk diffusion (KB)L277-4Hetacillin [Susceptibility] by Serum bactericidal titerL278-2Imipenem [Susceptibility] by Minimum lethal concentration (MLC)L281-6Imipenem [Susceptibility] by Serum bactericidal titerL286-5Isoniazid [Susceptibility] by Minimum lethal concentration (MLC)L288-1Isoniazid [Susceptibility] by Disk diffusion (KB)L289-9Isoniazid [Susceptibility] by Serum bactericidal titerL290-7Kanamycin [Susceptibility] by Minimum lethal concentration (MLC)L291-5Kanamycin [Susceptibility] by Minimum inhibitory concentration (MIC)L292-3Kanamycin [Susceptibility] by Disk diffusion (KB)L293-1Kanamycin [Susceptibility] by Serum bactericidal titerL294-9Ketoconazole [Susceptibility] by Minimum lethal concentration (MLC)L296-4Ketoconazole [Susceptibility] by Disk diffusion (KB)L297-2Ketoconazole [Susceptibility] by Serum bactericidal titerL298-0Lincomycin [Susceptibility] by Minimum lethal concentration (MLC)L299-8Lincomycin [Susceptibility] by Minimum inhibitory concentration (MIC)L3-4Almecillin [Susceptibility] by Minimum inhibitory concentration (MIC)L30-7Ampicillin [Susceptibility] by Serum bactericidal titerL300-4Lincomycin [Susceptibility] by Disk diffusion (KB)L301-2Lincomycin [Susceptibility] by Serum bactericidal titerL302-0Lomefloxacin [Susceptibility] by Minimum lethal concentration (MLC)L30269-5lamiVUDine [Susceptibility] by Phenotype methodL30271-1Zalcitabine [Susceptibility] by Phenotype methodL30274-5Adefovir [Susceptibility] by Phenotype methodL30276-0Delavirdine [Susceptibility] by Phenotype methodL30279-4Ritonavir [Susceptibility] by Phenotype methodL30281-0Saquinavir [Susceptibility] by Phenotype methodL30285-1Zalcitabine [Susceptibility] by Genotype methodL30290-1Delavirdine [Susceptibility] by Genotype methodL30296-8Amprenavir [Susceptibility] by Phenotype methodL30298-4lamiVUDine [Susceptibility]L30300-8Didanosine [Susceptibility]L30301-6Zalcitabine [Susceptibility]L30302-4Stavudine [Susceptibility]L30303-2Abacavir [Susceptibility]L30304-0Adefovir [Susceptibility]L30305-7Delavirdine [Susceptibility]L30306-5Efavirenz [Susceptibility]L30307-3Indinavir [Susceptibility]L30308-1Ritonavir [Susceptibility]L30309-9Nelfinavir [Susceptibility]L30310-7Saquinavir [Susceptibility]L30311-5Nevirapine [Susceptibility]L305-3Lomefloxacin [Susceptibility] by Serum bactericidal titerL306-1Loracarbef [Susceptibility] by Minimum lethal concentration (MLC)L307-9Loracarbef [Susceptibility] by Minimum inhibitory concentration (MIC)L309-5Loracarbef [Susceptibility] by Serum bactericidal titerL31-5Ampicillin+Sulbactam [Susceptibility] by Minimum lethal concentration (MLC)L310-3Lymecycline [Susceptibility] by Minimum lethal concentration (MLC)L31036-7Gatifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)L31040-9Gatifloxacin [Susceptibility] by Disk diffusion (KB)L31042-5Gatifloxacin [Susceptibility] by Gradient stripL31043-3Moxifloxacin [Susceptibility] by Gradient stripL311-1Lymecycline [Susceptibility] by Minimum inhibitory concentration (MIC)L31139-9Cefotaxime [Susceptibility] for meningitis by Gradient stripL31142-3Cefepime [Susceptibility] for meningitis by Minimum inhibitory concentration (MIC)L31143-1Cefepime [Susceptibility] for meningitis by Gradient stripL312-9Lymecycline [Susceptibility] by Disk diffusion (KB)L313-7Lymecycline [Susceptibility] by Serum bactericidal titerL314-5Meclocycline [Susceptibility] by Minimum lethal concentration (MLC)L315-2Meclocycline [Susceptibility] by Minimum inhibitory concentration (MIC)L316-0Meclocycline [Susceptibility] by Disk diffusion (KB)L317-8Meclocycline [Susceptibility] by Serum bactericidal titerL318-6Methacycline [Susceptibility] by Minimum lethal concentration (MLC)L319-4Methacycline [Susceptibility] by Minimum inhibitory concentration (MIC)L320-2Methacycline [Susceptibility] by Disk diffusion (KB)L321-0Methacycline [Susceptibility] by Serum bactericidal titerL322-8Methicillin [Susceptibility] by Minimum lethal concentration (MLC)L323-6Methicillin [Susceptibility] by Minimum inhibitory concentration (MIC)L32372-5Fleroxacin [Susceptibility]L32373-3Arbekacin [Susceptibility]L32374-1Cefotiam [Susceptibility]L32375-8Cefmenoxime [Susceptibility]L32376-6Clinafloxacin [Susceptibility]L32377-4Cefetamet [Susceptibility]L32381-6Isepamicin [Susceptibility]L32383-2Pristinamycin [Susceptibility]L32384-0Thiacetazone [Susceptibility]L324-4Methicillin [Susceptibility] by Disk diffusion (KB)L325-1Methicillin [Susceptibility] by Serum bactericidal titerL32597-7Natamycin [Susceptibility]L326-9metroNIDAZOLE [Susceptibility] by Minimum lethal concentration (MLC)L328-5metroNIDAZOLE [Susceptibility] by Disk diffusion (KB)L329-3metroNIDAZOLE [Susceptibility] by Serum bactericidal titerL330-1Mezlocillin [Susceptibility] by Minimum lethal concentration (MLC)L333-5Mezlocillin [Susceptibility] by Serum bactericidal titerL33334-4Quinupristin+Dalfopristin [Susceptibility] by Gradient stripL334-3Minocycline [Susceptibility] by Minimum lethal concentration (MLC)L33627-1Tenofovir [Susceptibility]L33628-9Cidofovir [Susceptibility]L33632-1Cytomegalovirus UL54+UL97 gene mutations detected [Identifier]L337-6Minocycline [Susceptibility] by Serum bactericidal titerL338-4Miocamycin [Susceptibility] by Minimum lethal concentration (MLC)L339-2Miocamycin [Susceptibility] by Minimum inhibitory concentration (MIC)L34-9Ampicillin+Sulbactam [Susceptibility] by Serum bactericidal titerL340-0Miocamycin [Susceptibility] by Disk diffusion (KB)L341-8Miocamycin [Susceptibility] by Serum bactericidal titerL342-6Moxalactam [Susceptibility] by Minimum lethal concentration (MLC)L343-4Moxalactam [Susceptibility] by Minimum inhibitory concentration (MIC)L344-2Moxalactam [Susceptibility] by Disk diffusion (KB)L345-9Moxalactam [Susceptibility] by Serum bactericidal titerL346-7Nafcillin [Susceptibility] by Minimum lethal concentration (MLC)L347-5Nafcillin [Susceptibility] by Minimum inhibitory concentration (MIC)L348-3Nafcillin [Susceptibility] by Disk diffusion (KB)L349-1Nafcillin [Susceptibility] by Serum bactericidal titerL35-6Azithromycin [Susceptibility] by Minimum lethal concentration (MLC)L350-9Nalidixate [Susceptibility] by Minimum lethal concentration (MLC)L353-3Nalidixate [Susceptibility] by Serum bactericidal titerL354-1Neomycin [Susceptibility] by Minimum lethal concentration (MLC)L355-8Neomycin [Susceptibility] by Minimum inhibitory concentration (MIC)L357-4Neomycin [Susceptibility] by Serum bactericidal titerL35754-1Avilamycin [Susceptibility] by Disk diffusion (KB)L35755-8Avilamycin [Susceptibility] by Minimum inhibitory concentration (MIC)L35756-6Avilamycin [Susceptibility]L35757-4Cefdinir [Susceptibility] by Gradient stripL35758-2Cefdinir [Susceptibility] by Disk diffusion (KB)L35759-0Cefditoren [Susceptibility] by Disk diffusion (KB)L35760-8Cefditoren [Susceptibility] by Gradient stripL35761-6Cefditoren [Susceptibility] by Minimum inhibitory concentration (MIC)L35762-4Cefditoren [Susceptibility]L35763-2Cefepime+Clavulanate [Susceptibility] by Gradient stripL35764-0Cefetamet [Susceptibility] by Disk diffusion (KB)L35765-7Cefetamet [Susceptibility] by Minimum inhibitory concentration (MIC)L35766-5Cefixime [Susceptibility] by Gradient stripL35767-3Cefoperazone [Susceptibility] by Gradient stripL35768-1Cefoperazone+Sulbactam [Susceptibility] by Gradient stripL35769-9Cefotaxime+Clavulanate [Susceptibility] by Disk diffusion (KB)L35770-7Cefotaxime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)L35771-5Cefotaxime+Clavulanate [Susceptibility]L35772-3Cefotiam [Susceptibility] by Disk diffusion (KB)L35773-1Cefotiam [Susceptibility] by Minimum inhibitory concentration (MIC)L35774-9cefTAZidime+Clavulanate [Susceptibility] by Disk diffusion (KB)L35775-6cefTAZidime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)L35776-4cefTAZidime+Clavulanate [Susceptibility]L35777-2Ceftibuten [Susceptibility] by Disk diffusion (KB)L35778-0Ceftibuten [Susceptibility] by Minimum inhibitory concentration (MIC)L35779-8Ceftibuten [Susceptibility]L35780-6Ceftiofur [Susceptibility] by Disk diffusion (KB)L35781-4Ceftiofur [Susceptibility] by Minimum inhibitory concentration (MIC)L35784-8Cephalexin [Susceptibility] by Gradient stripL35785-5Clinafloxacin [Susceptibility] by Disk diffusion (KB)L35786-3Clinafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)L35787-1DAPTOmycin [Susceptibility] by Disk diffusion (KB)L35790-5Difloxacin [Susceptibility] by Disk diffusion (KB)L35791-3Difloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)L35792-1Difloxacin [Susceptibility]L35793-9Dirithromycin [Susceptibility] by Disk diffusion (KB)L35794-7Dirithromycin [Susceptibility] by Minimum inhibitory concentration (MIC)L35795-4Dirithromycin [Susceptibility]L35796-2Enrofloxacin [Susceptibility] by Gradient stripL35797-0Enrofloxacin [Susceptibility] by Disk diffusion (KB)L35798-8Enrofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)L358-2Netilmicin [Susceptibility] by Minimum lethal concentration (MLC)L35800-2Ertapenem [Susceptibility] by Gradient stripL35803-6Bambermycins [Susceptibility] by Disk diffusion (KB)L35804-4Bambermycins [Susceptibility] by Minimum inhibitory concentration (MIC)L35805-1Bambermycins [Susceptibility]L35806-9Fleroxacin [Susceptibility] by Disk diffusion (KB)L35807-7Florfenicol [Susceptibility] by Disk diffusion (KB)L35808-5Florfenicol [Susceptibility] by Minimum inhibitory concentration (MIC)L35811-9Garenoxacin [Susceptibility] by Disk diffusion (KB)L35812-7Garenoxacin [Susceptibility] by Minimum inhibitory concentration (MIC)L35813-5Garenoxacin [Susceptibility]L35814-3Gemifloxacin [Susceptibility] by Disk diffusion (KB)L35815-0Gemifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)L35816-8Gemifloxacin [Susceptibility]L35817-6Gentamicin [Susceptibility] by Gradient strip.High potencyL35818-4Grepafloxacin [Susceptibility] by Disk diffusion (KB)L35819-2Imipenem+EDTA [Susceptibility] by Gradient stripL35820-0Isepamicin [Susceptibility] by Disk diffusion (KB)L35821-8Isepamicin [Susceptibility] by Minimum inhibitory concentration (MIC)L35822-6Mupirocin [Susceptibility] by Disk diffusion (KB)L35823-4Mupirocin [Susceptibility] by Minimum inhibitory concentration (MIC)L35824-2Nystatin [Susceptibility] by Disk diffusion (KB)L35825-9Orbifloxacin [Susceptibility] by Disk diffusion (KB)L35826-7Orbifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)L35827-5Orbifloxacin [Susceptibility]L35828-3Pefloxacin [Susceptibility] by Disk diffusion (KB)L35829-1Pirlimycin [Susceptibility] by Disk diffusion (KB)L35830-9Pirlimycin [Susceptibility] by Minimum inhibitory concentration (MIC)L35831-7Pirlimycin [Susceptibility]L35832-5Polymyxin B [Susceptibility] by Gradient stripL35833-3Pristinamycin [Susceptibility] by Disk diffusion (KB)L35834-1Pristinamycin [Susceptibility] by Minimum inhibitory concentration (MIC)L35835-8Quinupristin+Dalfopristin [Susceptibility] by Disk diffusion (KB)L35836-6Salinomycin [Susceptibility] by Disk diffusion (KB)L35837-4Salinomycin [Susceptibility] by Minimum inhibitory concentration (MIC)L35838-2Salinomycin [Susceptibility]L35839-0Sparfloxacin [Susceptibility] by Disk diffusion (KB)L35840-8Spectinomycin [Susceptibility] by Gradient stripL35841-6Streptomycin [Susceptibility] by Gradient strip.High potencyL35842-4Sulfonamide [Susceptibility] by Gradient stripL35843-2Telithromycin [Susceptibility] by Disk diffusion (KB)L35844-0Telithromycin [Susceptibility] by Minimum inhibitory concentration (MIC)L35845-7Telithromycin [Susceptibility]L35846-5Tiamulin [Susceptibility] by Disk diffusion (KB)L35847-3Tiamulin [Susceptibility] by Minimum inhibitory concentration (MIC)L35848-1Tiamulin [Susceptibility]L35849-9Tilmicosin [Susceptibility] by Disk diffusion (KB)L35850-7Tilmicosin [Susceptibility] by Minimum inhibitory concentration (MIC)L35851-5Tilmicosin [Susceptibility]L35852-3Trospectinomycin [Susceptibility] by Disk diffusion (KB)L35853-1Trospectinomycin [Susceptibility] by Minimum inhibitory concentration (MIC)L35854-9Trospectinomycin [Susceptibility]L35855-6Trovafloxacin [Susceptibility] by Disk diffusion (KB)L35856-4Tylosin [Susceptibility] by Disk diffusion (KB)L35857-2Tylosin [Susceptibility] by Minimum inhibitory concentration (MIC)L35858-0Tylosin [Susceptibility]L35859-8Virginiamycin [Susceptibility] by Disk diffusion (KB)L35860-6Virginiamycin [Susceptibility] by Minimum inhibitory concentration (MIC)L35861-4Virginiamycin [Susceptibility]L35862-2Voriconazole [Susceptibility] by Gradient stripL35872-1Penicillin+Novobiocin [Susceptibility] by Disk diffusion (KB)L35873-9Penicillin+Novobiocin [Susceptibility] by Minimum inhibitory concentration (MIC)L35874-7Penicillin+Novobiocin [Susceptibility]L360-8Netilmicin [Susceptibility] by Disk diffusion (KB)L361-6Netilmicin [Susceptibility] by Serum bactericidal titerL362-4Nitrofurantoin [Susceptibility] by Minimum lethal concentration (MLC)L365-7Nitrofurantoin [Susceptibility] by Serum bactericidal titerL369-9Norfloxacin [Susceptibility] by Serum bactericidal titerL370-7Novobiocin [Susceptibility] by Minimum lethal concentration (MLC)L371-5Novobiocin [Susceptibility] by Minimum inhibitory concentration (MIC)L372-3Novobiocin [Susceptibility] by Disk diffusion (KB)L373-1Novobiocin [Susceptibility] by Serum bactericidal titerL374-9Ofloxacin [Susceptibility] by Minimum lethal concentration (MLC)L377-2Ofloxacin [Susceptibility] by Serum bactericidal titerL378-0Oleandomycin [Susceptibility] by Minimum lethal concentration (MLC)L379-8Oleandomycin [Susceptibility] by Minimum inhibitory concentration (MIC)L38-0Azithromycin [Susceptibility] by Serum bactericidal titerL380-6Oleandomycin [Susceptibility] by Disk diffusion (KB)L381-4Oleandomycin [Susceptibility] by Serum bactericidal titerL382-2Oxacillin [Susceptibility] by Minimum lethal concentration (MLC)L385-5Oxacillin [Susceptibility] by Serum bactericidal titerL386-3Oxytetracycline [Susceptibility] by Minimum lethal concentration (MLC)L387-1Oxytetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)L388-9Oxytetracycline [Susceptibility] by Disk diffusion (KB)L389-7Oxytetracycline [Susceptibility] by Serum bactericidal titerL39-8Azlocillin [Susceptibility] by Minimum lethal concentration (MLC)L390-5Pefloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)L391-3Penicillin G [Susceptibility] by Minimum lethal concentration (MLC)L394-7Penicillin G [Susceptibility] by Serum bactericidal titerL397-0Penicillin V [Susceptibility] by Disk diffusion (KB)L398-8Penicillin V [Susceptibility] by Serum bactericidal titerL399-6Phenethicillin [Susceptibility] by Minimum lethal concentration (MLC)L4-2Almecillin [Susceptibility] by Disk diffusion (KB)L40-6Azlocillin [Susceptibility] by Minimum inhibitory concentration (MIC)L400-2Phenethicillin [Susceptibility] by Minimum inhibitory concentration (MIC)L401-0Phenethicillin [Susceptibility] by Disk diffusion (KB)L402-8Phenethicillin [Susceptibility] by Serum bactericidal titerL403-6Pipemidate [Susceptibility] by Minimum lethal concentration (MLC)L404-4Pipemidate [Susceptibility] by Minimum inhibitory concentration (MIC)L405-1Pipemidate [Susceptibility] by Disk diffusion (KB)L406-9Pipemidate [Susceptibility] by Serum bactericidal titerL407-7Piperacillin [Susceptibility] by Minimum lethal concentration (MLC)L41-4Azlocillin [Susceptibility] by Disk diffusion (KB)L410-1Piperacillin [Susceptibility] by Serum bactericidal titerL411-9Piperacillin+Tazobactam [Susceptibility] by Minimum lethal concentration (MLC)L41199-1Voriconazole [Susceptibility] by Minimum lethal concentration (MLC)L41200-7Voriconazole [Susceptibility] by Disk diffusion (KB)L414-3Piperacillin+Tazobactam [Susceptibility] by Serum bactericidal titerL41408-6Ofloxacin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 1.0 ug/mLL41409-4Ofloxacin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 2.0 ug/mLL41410-2Ofloxacin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 4.0 ug/mLL41494-6Gatifloxacin [Susceptibility] by Method for Slow-growing mycobacteriaL415-0Pivampicillin [Susceptibility] by Minimum lethal concentration (MLC)L41500-0Linezolid [Susceptibility] by Method for Slow-growing mycobacteriaL41502-6Moxifloxacin [Susceptibility] by Method for Slow-growing mycobacteriaL41504-2Norfloxacin [Susceptibility] by Method for Slow-growing mycobacteriaL416-8Pivampicillin [Susceptibility] by Minimum inhibitory concentration (MIC)L41658-6ABT492 [Susceptibility] by Minimum inhibitory concentration (MIC)L41660-2ABT492 [Susceptibility] by Gradient stripL41661-0Azlocillin [Susceptibility] by Gradient stripL41662-8Aztreonam+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)L41663-6Aztreonam+Clavulanate [Susceptibility] by Disk diffusion (KB)L41664-4Aztreonam+Clavulanate [Susceptibility] by Gradient stripL41665-1Biapenem [Susceptibility] by Minimum inhibitory concentration (MIC)L41666-9Biapenem [Susceptibility] by Disk diffusion (KB)L41667-7Biapenem [Susceptibility] by Gradient stripL41668-5Carbenicillin [Susceptibility] by Gradient stripL41669-3Cefamandole [Susceptibility] by Gradient stripL41670-1ceFAZolin [Susceptibility] by Gradient stripL41671-9Cefotaxime+Clavulanate [Susceptibility] by Gradient stripL41672-7cefoTEtan+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)L41673-5cefoTEtan+Clavulanate [Susceptibility] by Disk diffusion (KB)L41674-3cefoTEtan+Clavulanate [Susceptibility] by Gradient stripL41676-8cefOXitin+Clavulanate [Susceptibility] by Disk diffusion (KB)L41677-6cefOXitin+Clavulanate [Susceptibility] by Gradient stripL41678-4Cefpodoxime+Clavulanate [Susceptibility] by Gradient stripL41679-2Cefpodoxime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)L41680-0Cefpodoxime+Clavulanate [Susceptibility] by Disk diffusion (KB)L41681-8cefTRIAXone+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)L41682-6cefTRIAXone+Clavulanate [Susceptibility] by Disk diffusion (KB)L41683-4cefTRIAXone+Clavulanate [Susceptibility] by Gradient stripL41684-2Cephaloridine [Susceptibility] by Gradient stripL41685-9Clavulanate [Susceptibility] by Gradient stripL41686-7Clavulanate [Susceptibility] by Disk diffusion (KB)L41687-5Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)L41689-1Dalbavancin [Susceptibility] by Minimum inhibitory concentration (MIC)L41690-9Dalbavancin [Susceptibility] by Gradient stripL41692-5Enoxacin [Susceptibility] by Gradient stripL41693-3Ethionamide [Susceptibility] by Disk diffusion (KB)L41694-1Everninomicin [Susceptibility] by Minimum inhibitory concentration (MIC)L41695-8Everninomicin [Susceptibility] by Gradient stripL41696-6Everninomicin [Susceptibility] by Disk diffusion (KB)L41697-4Gemifloxacin [Susceptibility] by Gradient stripL41698-2Josamycine [Susceptibility] by Disk diffusion (KB)L41699-0Josamycine [Susceptibility] by Gradient stripL417-6Pivampicillin [Susceptibility] by Disk diffusion (KB)L41700-6Lincomycin [Susceptibility] by Gradient stripL41701-4Lomefloxacin [Susceptibility] by Gradient stripL41702-2Mezlocillin [Susceptibility] by Gradient stripL41703-0Moxalactam [Susceptibility] by Gradient stripL41704-8Nafcillin [Susceptibility] by Gradient stripL41705-5Neomycin [Susceptibility] by Gradient stripL41706-3Novobiocin [Susceptibility] by Gradient stripL41707-1Oritavancin [Susceptibility] by Disk diffusion (KB)L41708-9Oritavancin [Susceptibility] by Minimum inhibitory concentration (MIC)L41709-7Oritavancin [Susceptibility] by Gradient stripL41710-5Ramoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)L41711-3Ramoplanin [Susceptibility] by Gradient stripL41712-1Ramoplanin [Susceptibility] by Disk diffusion (KB)L41713-9Rosamicin [Susceptibility] by Minimum inhibitory concentration (MIC)L41714-7Rosamicin [Susceptibility] by Gradient stripL41715-4Rosamicin [Susceptibility] by Disk diffusion (KB)L41716-2Sulbactam [Susceptibility] by Disk diffusion (KB)L41717-0Sulbactam [Susceptibility] by Gradient stripL41718-8Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC)L41719-6Tazobactam [Susceptibility] by Disk diffusion (KB)L41720-4Tazobactam [Susceptibility] by Gradient stripL41721-2Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC)L41722-0Telithromycin [Susceptibility] by Gradient stripL41723-8Thiamphenicol [Susceptibility] by Disk diffusion (KB)L41724-6Thiamphenicol [Susceptibility] by Gradient stripL41725-3Thiamphenicol [Susceptibility] by Minimum inhibitory concentration (MIC)L41726-1ABT492 [Susceptibility]L41727-9Aztreonam+Clavulanate [Susceptibility]L41728-7Biapenem [Susceptibility]L41729-5cefoTEtan+Clavulanate [Susceptibility]L41730-3cefOXitin+Clavulanate [Susceptibility]L41731-1Cefpodoxime+Clavulanate [Susceptibility]L41732-9cefTRIAXone+Clavulanate [Susceptibility]L41733-7Clavulanate [Susceptibility]L41734-5Dalbavancin [Susceptibility]L41735-2Everninomicin [Susceptibility]L41736-0Oritavancin [Susceptibility]L41737-8Ramoplanin [Susceptibility]L41738-6Rosamicin [Susceptibility]L41739-4Sulbactam [Susceptibility]L41740-2Tazobactam [Susceptibility]L418-4Pivampicillin [Susceptibility] by Serum bactericidal titerL419-2Polymyxin B [Susceptibility] by Minimum lethal concentration (MLC)L41993-7Atazanavir [Susceptibility]L42-2Azlocillin [Susceptibility] by Serum bactericidal titerL420-0Polymyxin B [Susceptibility] by Minimum inhibitory concentration (MIC)L422-6Polymyxin B [Susceptibility] by Serum bactericidal titerL423-4Pyrazinamide [Susceptibility] by Minimum lethal concentration (MLC)L42350-9Cefepime+Clavulanate [Susceptibility] by Disk diffusion (KB)L42351-7Cefepime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)L42352-5cefTAZidime+Clavulanate [Susceptibility] by Gradient stripL42353-3Cefepime+Clavulanate [Susceptibility]L42354-1Tigecycline [Susceptibility] by Gradient stripL42356-6Tigecycline [Susceptibility] by Disk diffusion (KB)L425-9Pyrazinamide [Susceptibility] by Disk diffusion (KB)L42535-5Tipranavir [Susceptibility]L426-7Pyrazinamide [Susceptibility] by Serum bactericidal titerL42642-9Amikacin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 2.0 ug/mLL42651-0Isoniazid [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 5.0 ug/mLL42655-1Rifabutin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 0.5 ug/mLL427-5rifAMPin [Susceptibility] by Minimum lethal concentration (MLC)L43-0Aztreonam [Susceptibility] by Minimum lethal concentration (MLC)L430-9rifAMPin [Susceptibility] by Serum bactericidal titerL431-7Ristocetin [Susceptibility] by Minimum lethal concentration (MLC)L432-5Ristocetin [Susceptibility] by Minimum inhibitory concentration (MIC)L43269-0Ceftobiprole [Susceptibility] by Disk diffusion (KB)L43270-8Ceftobiprole [Susceptibility] by Minimum lethal concentration (MLC)L43271-6Ceftobiprole [Susceptibility] by Minimum inhibitory concentration (MIC)L43272-4Ceftobiprole [Susceptibility]L433-3Ristocetin [Susceptibility] by Disk diffusion (KB)L434-1Ristocetin [Susceptibility] by Serum bactericidal titerL435-8Rolitetracycline [Susceptibility] by Minimum lethal concentration (MLC)L436-6Rolitetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)L437-4Rolitetracycline [Susceptibility] by Disk diffusion (KB)L438-2Rolitetracycline [Susceptibility] by Serum bactericidal titerL439-0Rosoxacin [Susceptibility] by Minimum lethal concentration (MLC)L43986-9Clofazimine [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 2.0 ug/mLL43987-7Clarithromycin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 12.0 ug/mLL43988-5Clofazimine [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 0.5 ug/mLL43989-3Clofazimine [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 1.0 ug/mLL43990-1Clarithromycin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 3.0 ug/mLL43991-9Clarithromycin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 6.0 ug/mLL440-8Rosoxacin [Susceptibility] by Minimum inhibitory concentration (MIC)L441-6Rosoxacin [Susceptibility] by Disk diffusion (KB)L442-4Rosoxacin [Susceptibility] by Serum bactericidal titerL443-2Roxithromycin [Susceptibility] by Minimum lethal concentration (MLC)L444-0Roxithromycin [Susceptibility] by Minimum inhibitory concentration (MIC)L445-7Roxithromycin [Susceptibility] by Disk diffusion (KB)L446-5Roxithromycin [Susceptibility] by Serum bactericidal titerL447-3Sisomicin [Susceptibility] by Minimum lethal concentration (MLC)L448-1Sisomicin [Susceptibility] by Minimum inhibitory concentration (MIC)L449-9Sisomicin [Susceptibility] by Disk diffusion (KB)L450-7Sisomicin [Susceptibility] by Serum bactericidal titerL451-5Spectinomycin [Susceptibility] by Minimum lethal concentration (MLC)L452-3Spectinomycin [Susceptibility] by Minimum inhibitory concentration (MIC)L45215-1Isoniazid [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 2.0 ug/mLL454-9Spectinomycin [Susceptibility] by Serum bactericidal titerL455-6Spiramycin [Susceptibility] by Minimum lethal concentration (MLC)L456-4Spiramycin [Susceptibility] by Minimum inhibitory concentration (MIC)L457-2Spiramycin [Susceptibility] by Disk diffusion (KB)L458-0Spiramycin [Susceptibility] by Serum bactericidal titerL459-8Streptomycin [Susceptibility] by Minimum lethal concentration (MLC)L46-3Aztreonam [Susceptibility] by Serum bactericidal titerL461-4Streptomycin [Susceptibility] by Disk diffusion (KB)L462-2Streptomycin [Susceptibility] by Serum bactericidal titerL46244-0Mycobacterium tuberculosis complex rpoB gene rifAMPin resistance mutation identified by Molecular methodL46245-7Mycobacterium tuberculosis pncA gene pyrazinamide resistance mutation [Identifier] by Molecular methodL46246-5Mycobacterium tuberculosis katG gene isoniazid high level resistance mutation [Identifier] by Molecular methodL46247-3Mycobacterium tuberculosis embB gene ethambutol resistance mutation [Identifier] by Molecular methodL463-0sulfADIAZINE [Susceptibility] by Minimum lethal concentration (MLC)L464-8sulfADIAZINE [Susceptibility] by Minimum inhibitory concentration (MIC)L465-5sulfADIAZINE [Susceptibility] by Disk diffusion (KB)L466-3sulfADIAZINE [Susceptibility] by Serum bactericidal titerL467-1Sulfamethoxazole [Susceptibility] by Minimum lethal concentration (MLC)L46719-1Streptomycin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 4.0 ug/mLL468-9Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)L469-7Sulfamethoxazole [Susceptibility] by Disk diffusion (KB)L47-1Bacampicillin [Susceptibility] by Minimum lethal concentration (MLC)L470-5Sulfamethoxazole [Susceptibility] by Serum bactericidal titerL471-3sulfiSOXAZOLE [Susceptibility] by Minimum lethal concentration (MLC)L472-1sulfiSOXAZOLE [Susceptibility] by Minimum inhibitory concentration (MIC)L474-7sulfiSOXAZOLE [Susceptibility] by Serum bactericidal titerL475-4Sulfonamide [Susceptibility] by Minimum lethal concentration (MLC)L476-2Sulfonamide [Susceptibility] by Minimum inhibitory concentration (MIC)L477-0Sulfonamide [Susceptibility] by Disk diffusion (KB)L478-8Sulfonamide [Susceptibility] by Serum bactericidal titerL479-6Talampicillin [Susceptibility] by Minimum lethal concentration (MLC)L48-9Bacampicillin [Susceptibility] by Minimum inhibitory concentration (MIC)L480-4Talampicillin [Susceptibility] by Minimum inhibitory concentration (MIC)L481-2Talampicillin [Susceptibility] by Disk diffusion (KB)L48169-7Amikacin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 1.5 ug/mLL48170-5Capreomycin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 3.0 ug/mLL48173-9levoFLOXacin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 1.5 ug/mLL48175-4Mycobacterium tuberculosis katG + inhA gene isoniazid resistance mutation [Presence] by Molecular methodL482-0Talampicillin [Susceptibility] by Serum bactericidal titerL483-8Teicoplanin [Susceptibility] by Minimum lethal concentration (MLC)L484-6Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)L485-3Teicoplanin [Susceptibility] by Disk diffusion (KB)L486-1Teicoplanin [Susceptibility] by Serum bactericidal titerL48611-8Antibiotic tested [Identifier] against isolateL48685-2Para aminosalicylate [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 10.0 ug/mLL487-9Temafloxacin [Susceptibility] by Minimum lethal concentration (MLC)L488-7Temafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)L489-5Temafloxacin [Susceptibility] by Disk diffusion (KB)L49-7Bacampicillin [Susceptibility] by Disk diffusion (KB)L490-3Temafloxacin [Susceptibility] by Serum bactericidal titerL49080-5Kanamycin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 1.0 ug/mLL491-1Temocillin [Susceptibility] by Minimum lethal concentration (MLC)L492-9Temocillin [Susceptibility] by Minimum inhibitory concentration (MIC)L493-7Temocillin [Susceptibility] by Disk diffusion (KB)L494-5Temocillin [Susceptibility] by Serum bactericidal titerL495-2Tetracycline [Susceptibility] by Minimum lethal concentration (MLC)L49666-1Darunavir [Susceptibility] by Phenotype methodL49667-9Tipranavir [Susceptibility] by Phenotype methodL49669-5Emtricitabine [Susceptibility] by Phenotype methodL498-6Tetracycline [Susceptibility] by Serum bactericidal titerL49877-4Hepatitis B virus codon 173 [Identifier] by Genotype methodL49878-2Hepatitis B virus codon 180 [Identifier] by Genotype methodL49879-0Hepatitis B virus codon 181 [Identifier] by Genotype methodL49880-8Hepatitis B virus codon 204 [Identifier] by Genotype methodL49881-6Hepatitis B virus codon 236 [Identifier] by Genotype methodL49882-4Hepatitis B virus codon 80 [Identifier] by Genotype methodL499-4Ticarcillin [Susceptibility] by Minimum lethal concentration (MLC)L5-9Almecillin [Susceptibility] by Serum bactericidal titerL50-5Bacampicillin [Susceptibility] by Serum bactericidal titerL502-5Ticarcillin [Susceptibility] by Serum bactericidal titerL503-3Ticarcillin+Clavulanate [Susceptibility] by Minimum lethal concentration (MLC)L506-6Ticarcillin+Clavulanate [Susceptibility] by Serum bactericidal titerL50630-3Gentamicin [Susceptibility] by Method for Slow-growing mycobacteriaL50631-1Cefepime [Susceptibility] by Method for Slow-growing mycobacteriaL50632-9Cefotaxime [Susceptibility] by Method for Slow-growing mycobacteriaL50698-0Influenza virus A.adamantane resistance [Presence] by Phenotype methodL50699-8Influenza virus A.adamantane resistance [Presence]L507-4Tobramycin [Susceptibility] by Minimum lethal concentration (MLC)L50700-4Influenza virus A.adamantane resistant RNA [Presence] by NAA with probe detectionL50703-8Influenza virus A.neuraminidase inhibitor resistance [Susceptibility] Qualitative by Phenotype methodL50712-9Influenza virus.neuraminidase inhibitor resistance [Susceptibility] QualitativeL50713-7Influenza virus.neuraminidase inhibitor resistance [Susceptibility] by Genotype methodL51-3Butirosin [Susceptibility] by Minimum lethal concentration (MLC)L510-8Tobramycin [Susceptibility] by Serum bactericidal titerL511-6Trimethoprim [Susceptibility] by Minimum lethal concentration (MLC)L514-0Trimethoprim [Susceptibility] by Serum bactericidal titerL515-7Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum lethal concentration (MLC)L51504-9Penicillin G benzathine [Susceptibility]L51694-8Carumonam [Susceptibility]L51698-9Dapsone [Susceptibility]L51719-3Paromomycin [Susceptibility]L518-1Trimethoprim+Sulfamethoxazole [Susceptibility] by Serum bactericidal titerL519-9Troleandomycin [Susceptibility] by Minimum lethal concentration (MLC)L52-1Butirosin [Susceptibility] by Minimum inhibitory concentration (MIC)L520-7Troleandomycin [Susceptibility] by Minimum inhibitory concentration (MIC)L521-5Troleandomycin [Susceptibility] by Disk diffusion (KB)L522-3Troleandomycin [Susceptibility] by Serum bactericidal titerL523-1Vancomycin [Susceptibility] by Minimum lethal concentration (MLC)L526-4Vancomycin [Susceptibility] by Serum bactericidal titerL527-2Viomycin [Susceptibility] by Minimum lethal concentration (MLC)L528-0Viomycin [Susceptibility] by Minimum inhibitory concentration (MIC)L529-8Viomycin [Susceptibility] by Disk diffusion (KB)L53-9Butirosin [Susceptibility] by Disk diffusion (KB)L530-6Viomycin [Susceptibility] by Serum bactericidal titerL531-4Zidovudine [Susceptibility]L53716-7levoFLOXacin [Susceptibility] by Method for Slow-growing mycobacteriaL53818-1Arbekacin [Susceptibility] by Minimum inhibitory concentration (MIC)L53820-7Cefozopran [Susceptibility] by Minimum inhibitory concentration (MIC)L53822-3Flomoxef [Susceptibility] by Minimum inhibitory concentration (MIC)L53823-1Panipenem [Susceptibility] by Minimum inhibitory concentration (MIC)L53824-9Paromomycin [Susceptibility] by Minimum inhibitory concentration (MIC)L54-7Butirosin [Susceptibility] by Serum bactericidal titerL54166-4Cefoperazone+Sulbactam [Susceptibility]L54167-2Cefoperazone+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC)L54168-0Cefoperazone+Sulbactam [Susceptibility] by Disk diffusion (KB)L54169-8Thiamphenicol [Susceptibility]L54170-6Imipenem+EDTA [Susceptibility]L54171-4Imipenem+EDTA [Susceptibility] by Minimum inhibitory concentration (MIC)L54172-2Imipenem+EDTA [Susceptibility] by Disk diffusion (KB)L54173-0Arbekacin [Susceptibility] by Disk diffusion (KB)L54174-8Cefmenoxime [Susceptibility] by Disk diffusion (KB)L54175-5Caspofungin [Susceptibility] by Disk diffusion (KB)L54177-1Clotrimazole [Susceptibility] by Disk diffusion (KB)L54178-9Econazole [Susceptibility] by Disk diffusion (KB)L54179-7Itraconazole [Susceptibility] by Disk diffusion (KB)L54180-5Miconazole [Susceptibility] by Disk diffusion (KB)L54181-3Nitroxoline [Susceptibility] by Disk diffusion (KB)L54182-1Para aminosalicylate [Susceptibility] by Disk diffusion (KB)L54183-9Rifabutin [Susceptibility] by Disk diffusion (KB)L54184-7Thiacetazone [Susceptibility] by Disk diffusion (KB)L54185-4Caspofungin [Susceptibility] by Gradient stripL54186-2Posaconazole [Susceptibility] by Gradient stripL54188-8Posaconazole [Susceptibility]L54189-6Posaconazole [Susceptibility] by Disk diffusion (KB)L54190-4Temocillin [Susceptibility] by Gradient stripL54191-2Cefotaxime+Sulbactam [Susceptibility]L54192-0Cefotaxime+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC)L54193-8Cefotaxime+Sulbactam [Susceptibility] by Disk diffusion (KB)L54194-6Mezlocillin+Sulbactam [Susceptibility]L54195-3Mezlocillin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC)L54196-1Mezlocillin+Sulbactam [Susceptibility] by Disk diffusion (KB)L54197-9Piperacillin+Sulbactam [Susceptibility]L54198-7Piperacillin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC)L54199-5Piperacillin+Sulbactam [Susceptibility] by Disk diffusion (KB)L54200-1Griseofulvin [Susceptibility]L54202-7Griseofulvin [Susceptibility] by Disk diffusion (KB)L54203-5Cefmenoxime [Susceptibility] by Minimum inhibitory concentration (MIC)L54204-3Thiacetazone [Susceptibility] by Minimum inhibitory concentration (MIC)L54908-9Cefminox [Susceptibility]L54928-7Tinidazole [Susceptibility]L55-4Capreomycin [Susceptibility] by Minimum lethal concentration (MLC)L55154-9Ethambutol+rifAMPin [Susceptibility] by Method for Slow-growing mycobacteriaL55156-4Minocycline [Susceptibility] by Method for Slow-growing mycobacteriaL55158-0Tigecycline [Susceptibility] by Method for Slow-growing mycobacteriaL55189-5Cefotaxime [Susceptibility] for meningitis by Disk diffusion (KB)L55190-3cefTRIAXone [Susceptibility] for meningitis by Disk diffusion (KB)L55194-5Ciprofloxacin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 1.0 ug/mLL55196-0Terconazole [Susceptibility]L55289-3Sulopenem [Susceptibility]L55290-1Sulopenem [Susceptibility] by Minimum inhibitory concentration (MIC)L55291-9Sulopenem [Susceptibility] by Disk diffusion (KB)L55292-7Linopristin+Flopristin [Susceptibility]L55293-5Linopristin+Flopristin [Susceptibility] by Minimum inhibitory concentration (MIC)L55294-3Linopristin+Flopristin [Susceptibility] by Disk diffusion (KB)L55614-2Amoxicillin+Sulbactam [Susceptibility]L55615-9Amoxicillin+Sulbactam [Susceptibility] by Gradient stripL55616-7Amoxicillin+Sulbactam [Susceptibility] by Disk diffusion (KB)L55618-3Atovaquone [Susceptibility] by Minimum inhibitory concentration (MIC)L55619-1Avilamycin [Susceptibility] by Gradient stripL55620-9Bacampicillin [Susceptibility] by Gradient stripL55621-7Bambermycins [Susceptibility] by Gradient stripL55622-5Butirosin [Susceptibility] by Gradient stripL55623-3Capreomycin [Susceptibility] by Gradient stripL55624-1Cefacetrile [Susceptibility] by Minimum inhibitory concentration (MIC)L55625-8Cefacetrile [Susceptibility]L55626-6Cefacetrile [Susceptibility] by Disk diffusion (KB)L55627-4Cefacetrile [Susceptibility] by Gradient stripL55628-2Cefadroxil [Susceptibility] by Gradient stripL55629-0Cephaloglycin [Susceptibility] by Gradient stripL55630-8Cephalothin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC)L55631-6Cephalothin+Sulbactam [Susceptibility]L55632-4Cephalothin+Sulbactam [Susceptibility] by Disk diffusion (KB)L55633-2Cephalothin+Sulbactam [Susceptibility] by Gradient stripL55634-0Cefamandole+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC)L55635-7Cefamandole+Sulbactam [Susceptibility]L55636-5Cefamandole+Sulbactam [Susceptibility] by Disk diffusion (KB)L55637-3Cefamandole+Sulbactam [Susceptibility] by Gradient stripL55638-1Cephapirin [Susceptibility] by Gradient stripL55639-9Cefatrizine [Susceptibility] by Gradient stripL55640-7Cefetamet [Susceptibility] by Gradient stripL55641-5Cefmenoxime [Susceptibility] by Gradient stripL55642-3Cefonicid [Susceptibility] by Gradient stripL55643-1Ceforanide [Susceptibility] by Gradient stripL55644-9Cefotaxime+Sulbactam [Susceptibility] by Gradient stripL55645-6Cefotiam [Susceptibility] by Gradient stripL55646-4Cephradine [Susceptibility] by Gradient stripL55647-2Cefsulodin [Susceptibility] by Gradient stripL55648-0cefTAZidime+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC)L55649-8cefTAZidime+Sulbactam [Susceptibility]L55650-6cefTAZidime+Sulbactam [Susceptibility] by Disk diffusion (KB)L55651-4cefTAZidime+Sulbactam [Susceptibility] by Gradient stripL55652-2Ceftiofur [Susceptibility] by Gradient stripL55653-0Cefuroxime Oral [Susceptibility] by Gradient stripL55654-8Cefuroxime [Susceptibility] by Gradient stripL55655-5Chlortetracycline [Susceptibility] by Gradient stripL55656-3Cinoxacin [Susceptibility] by Gradient stripL55657-1Clindamycin [Susceptibility] by High potencyL55658-9Clindamycin [Susceptibility] by Gradient strip.High potencyL55659-7Clindamycin [Susceptibility] by Agar diffusion.High potencyL55660-5Clindamycin [Susceptibility] by MIC.High potencyL55661-3Clofazimine [Susceptibility] by Disk diffusion (KB)L55662-1Clofazimine [Susceptibility] by Gradient stripL55663-9Clotrimazole [Susceptibility] by Gradient stripL55664-7Cloxacillin [Susceptibility] by Gradient stripL55665-4Colistimethate by Gradient stripL55666-2Cyclacillin [Susceptibility] by Gradient stripL55667-0cycloSERINE [Susceptibility] by Gradient stripL55668-8Dicloxacillin [Susceptibility] by Gradient stripL55669-6Dibekacin [Susceptibility] by Minimum inhibitory concentration (MIC)L55670-4Dibekacin [Susceptibility]L55671-2Dibekacin [Susceptibility] by Disk diffusion (KB)L55672-0Dibekacin [Susceptibility] by Gradient stripL55673-8Econazole [Susceptibility] by Gradient stripL55674-6Ethambutol [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 2.0 ug/mLL55675-3Flumequine [Susceptibility] by Minimum inhibitory concentration (MIC)L55676-1Flumequine [Susceptibility]L55677-9Flumequine [Susceptibility] by Disk diffusion (KB)L55678-7Flumequine [Susceptibility] by Gradient stripL55679-5Framycetin [Susceptibility] by Gradient stripL55680-3Isepamicin [Susceptibility] by Gradient stripL55681-1Isoconazole [Susceptibility] by Minimum inhibitory concentration (MIC)L55682-9Isoconazole [Susceptibility]L55683-7Isoconazole [Susceptibility] by Disk diffusion (KB)L55684-5Isoconazole [Susceptibility] by Gradient stripL55685-2Isoniazid [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 10.0 ug/mLL55686-0Miconazole [Susceptibility] by Gradient stripL55687-8Miocamycin [Susceptibility] by Gradient stripL55688-6Nitroxoline [Susceptibility] by Gradient stripL55689-4Nystatin [Susceptibility] by Gradient stripL55690-2Oleandomycin [Susceptibility] by Gradient stripL55691-0Ornidazole [Susceptibility]L55692-8Ornidazole [Susceptibility] by Gradient stripL55693-6Ornidazole [Susceptibility] by Disk diffusion (KB)L55694-4Ornidazole [Susceptibility] by Minimum inhibitory concentration (MIC)L55695-1Oxolinate [Susceptibility] by Minimum inhibitory concentration (MIC)L55696-9Oxolinate [Susceptibility]L55697-7Oxolinate [Susceptibility] by Disk diffusion (KB)L55698-5Oxolinate [Susceptibility] by Gradient stripL55699-3Oxytetracycline [Susceptibility] by Gradient stripL55701-7Paromomycin [Susceptibility] by Disk diffusion (KB)L55702-5Paromomycin [Susceptibility] by Gradient stripL55703-3Pipemidate [Susceptibility] by Gradient stripL55704-1Piperacillin+Sulbactam [Susceptibility] by Gradient stripL55705-8Piromidate [Susceptibility] by Minimum inhibitory concentration (MIC)L55706-6Piromidate [Susceptibility]L55707-4Piromidate [Susceptibility] by Disk diffusion (KB)L55708-2Piromidate [Susceptibility] by Gradient stripL55709-0Pristinamycin [Susceptibility] by Gradient stripL55710-8Pyrazinamide [Susceptibility] by Gradient stripL55711-6Pyrazinamide [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 200.0 ug/mLL55712-4rifAMPin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 40.0 ug/mLL55713-2Rosoxacin [Susceptibility] by Gradient stripL55714-0Sisomicin [Susceptibility] by Gradient stripL55715-7Spiramycin [Susceptibility] by Gradient stripL55716-5Ticarcillin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC)L55717-3Ticarcillin+Sulbactam [Susceptibility]L55718-1Ticarcillin+Sulbactam [Susceptibility] by Disk diffusion (KB)L55719-9Ticarcillin+Sulbactam [Susceptibility] by Gradient stripL55720-7Tinidazole [Susceptibility] by Minimum inhibitory concentration (MIC)L55721-5Tinidazole [Susceptibility] by Disk diffusion (KB)L55722-3Tinidazole [Susceptibility] by Gradient stripL55723-1Virginiamycin [Susceptibility] by Gradient stripL55737-1Cefotiam hexetil [Susceptibility] by Minimum inhibitory concentration (MIC)L55738-9Cefotiam hexetil [Susceptibility]L55739-7Cefotiam hexetil [Susceptibility] by Disk diffusion (KB)L55740-5Cefotiam hexetil [Susceptibility] by Gradient stripL56-2Capreomycin [Susceptibility] by Minimum inhibitory concentration (MIC)L56025-0Ethambutol [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 8.0 ug/mLL56026-8Pyrazinamide [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 300.0 ug/mLL57-0Capreomycin [Susceptibility] by Disk diffusion (KB)L57895-5Influenza virus A H1.neuraminidase inhibitor resistance [Susceptibility] in Specimen by Genotype methodL57897-1Influenza virus A+B.neuraminidase inhibitor resistance [Susceptibility] in Specimen by Genotype methodL57997-9Lopinavir+Ritonavir [Susceptibility] by Phenotype methodL58-8Capreomycin [Susceptibility] by Serum bactericidal titerL58412-8Cefepime [Susceptibility] for meningitis by Disk diffusion (KB)L58705-5cefTAZidime [Susceptibility] by Method for Slow-growing mycobacteriaL58711-3Doripenem [Susceptibility] by Gradient stripL58712-1Quinupristin+Dalfopristin [Susceptibility] by Method for Slow-growing mycobacteriaL59-6Carbenicillin [Susceptibility] by Minimum lethal concentration (MLC)L59833-4Other Antibiotic [Susceptibility] by Minimum lethal concentration (MLC)L6-7Amantadine [Susceptibility]L60-4Carbenicillin [Susceptibility] by Minimum inhibitory concentration (MIC)L60440-5Oseltamivir [Susceptibility] by Genotype methodL60441-3Oseltamivir+Zanamivir [Susceptibility] by Genotype methodL60542-8Mupirocin 5 ug [Susceptibility] by Disk diffusion (KB)L60543-6Mupirocin 200 ug [Susceptibility] by Disk diffusion (KB)L60564-2Amikacin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 1.0 ug/mLL60565-9Amikacin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 4.0 ug/mLL61154-1Hepatitis B virus codon L180M [Presence] by Genotype methodL61155-8Hepatitis B virus codon L80V [Presence] by Genotype methodL61156-6Hepatitis B virus codon V173L [Presence] by Genotype methodL61157-4Hepatitis B virus codon M204V [Presence] by Genotype methodL61158-2Hepatitis B virus codon M204I [Presence] by Genotype methodL61159-0Hepatitis B virus codon M204S [Presence] by Genotype methodL61160-8Hepatitis B virus codon A181V [Presence] by Genotype methodL61161-6Hepatitis B virus codon A181T [Presence] by Genotype methodL61162-4Hepatitis B virus codon N236T [Presence] by Genotype methodL61163-2Hepatitis B virus codon A194T [Presence] by Genotype methodL61164-0Hepatitis B virus codon T184S [Presence] by Genotype methodL61165-7Hepatitis B virus codon T184I [Presence] by Genotype methodL61166-5Hepatitis B virus codon S202G [Presence] by Genotype methodL61167-3Hepatitis B virus codon S202C [Presence] by Genotype methodL61168-1Hepatitis B virus codon S202I [Presence] by Genotype methodL61169-9Hepatitis B virus codon I233V [Presence] by Genotype methodL61170-7Hepatitis B virus codon M250V [Presence] by Genotype methodL61171-5Hepatitis B virus codon M250I [Presence] by Genotype methodL61172-3Hepatitis B virus codon M250L [Presence] by Genotype methodL61173-1Hepatitis B virus codon L80I [Presence] by Genotype methodL61355-4Capreomycin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 5.0 ug/mLL62-0Carbenicillin [Susceptibility] by Serum bactericidal titerL62256-3Aminoglycoside resistance aacA gene [Presence] by Molecular methodL62258-9Erythromyin+clindamycin resistance ermA + ermC genes [Presence] by Molecular methodL62260-5Tetracycline resistance tetK + tetM genes [Presence] by Molecular methodL63-8Cefadroxil [Susceptibility] by Minimum lethal concentration (MLC)L63072-3Mycobacterium tuberculosis inhA gene isoniazid low level resistance mutation [Presence] by Molecular methodL63368-5Carbapenem resistance genes [Identifier] by NAA with probe detectionL63565-6Prothionamide [Susceptibility] by Method for Slow-growing mycobacteriaL64-6Cefadroxil [Susceptibility] by Minimum inhibitory concentration (MIC)L65-3Cefadroxil [Susceptibility] by Disk diffusion (KB)L65340-2Micafungin [Susceptibility]L66-1Cefadroxil [Susceptibility] by Serum bactericidal titerL6643-1Cefepime [Susceptibility] by Minimum lethal concentration (MLC)L6650-6Cefpirome [Susceptibility] by Serum bactericidal titerL6651-4Meropenem [Susceptibility] by Minimum lethal concentration (MLC)L6654-8Meropenem [Susceptibility] by Serum bactericidal titerL67-9Cefamandole [Susceptibility] by Minimum lethal concentration (MLC)L68-7Cefamandole [Susceptibility] by Minimum inhibitory concentration (MIC)L6827-0Bacitracin [Susceptibility] by Minimum inhibitory concentration (MIC)L69-5Cefamandole [Susceptibility] by Disk diffusion (KB)L69379-6Vancomycin resistance vanA and vanB and vanC1 and vanC2 genes [Identifier] by Molecular methodL69574-2Furazolidone [Susceptibility]L6975-7Amikacin [Susceptibility] by Gradient stripL6976-5Amoxicillin [Susceptibility] by Gradient stripL6977-3Amoxicillin+Clavulanate [Susceptibility] by Gradient stripL6978-1Amphotericin B [Susceptibility] by Gradient stripL6980-7Ampicillin+Sulbactam [Susceptibility] by Gradient stripL6981-5Azithromycin [Susceptibility] by Gradient stripL6982-3Aztreonam [Susceptibility] by Gradient stripL6983-1Bacitracin [Susceptibility] by Gradient stripL6986-4Cefaclor [Susceptibility] by Gradient stripL6987-2Cefepime [Susceptibility] by Gradient stripL6988-0Cefodizime [Susceptibility] by Gradient stripL6990-6cefoTEtan [Susceptibility] by Gradient stripL6991-4cefOXitin [Susceptibility] by Gradient stripL6992-2Cefpirome [Susceptibility] by Gradient stripL6993-0Cefpodoxime [Susceptibility] by Gradient stripL6994-8Cefprozil [Susceptibility] by Gradient stripL6995-5cefTAZidime [Susceptibility] by Gradient stripL6996-3Ceftibuten [Susceptibility] by Gradient stripL6997-1Ceftizoxime [Susceptibility] by Gradient stripL6999-7Cefuroxime Parenteral [Susceptibility] by Gradient stripL7-5Amdinocillin [Susceptibility] by Minimum lethal concentration (MLC)L70-3Cefamandole [Susceptibility] by Serum bactericidal titerL7001-1Chloramphenicol [Susceptibility] by Gradient stripL7002-9Ciprofloxacin [Susceptibility] by Gradient stripL7003-7Clarithromycin [Susceptibility] by Gradient stripL7004-5Clinafloxacin [Susceptibility] by Gradient stripL7006-0Demeclocycline [Susceptibility] by Gradient stripL7007-8Dirithromycin [Susceptibility] by Gradient stripL7008-6Doxycycline [Susceptibility] by Gradient stripL7010-2Ethambutol [Susceptibility] by Gradient stripL7011-0Ethionamide [Susceptibility] by Gradient stripL7012-8Fleroxacin [Susceptibility] by Gradient stripL7013-6Fluconazole [Susceptibility] by Gradient stripL7014-45-Fluorocytosine [Susceptibility] by Gradient stripL7015-1Fusidate [Susceptibility] by Gradient stripL7016-9Gentamicin [Susceptibility] by Gradient stripL7020-1Isoniazid [Susceptibility] by Gradient stripL7021-9Itraconazole [Susceptibility] by Gradient stripL7022-7Kanamycin [Susceptibility] by Gradient stripL7023-5Kanamycin [Susceptibility] by Agar diffusion.High potencyL7024-3Kanamycin [Susceptibility] by MIC.High potencyL7025-0Ketoconazole [Susceptibility] by Gradient stripL7027-6Loracarbef [Susceptibility] by Gradient stripL7028-4Amdinocillin [Susceptibility] by Gradient stripL7030-0Methicillin [Susceptibility] by Gradient stripL7031-8metroNIDAZOLE [Susceptibility] by Gradient stripL7032-6Minocycline [Susceptibility] by Gradient stripL7033-4Mupirocin [Susceptibility] by Gradient stripL7034-2Nalidixate [Susceptibility] by Gradient stripL7035-9Netilmicin [Susceptibility] by Gradient stripL7036-7Nitrofurantoin [Susceptibility] by Gradient stripL7037-5Norfloxacin [Susceptibility] by Gradient stripL7038-3Ofloxacin [Susceptibility] by Gradient stripL7039-1Oxacillin [Susceptibility] by Gradient stripL7040-9Pefloxacin [Susceptibility] by Gradient stripL7043-3Piperacillin [Susceptibility] by Gradient stripL7044-1Piperacillin+Tazobactam [Susceptibility] by Gradient stripL7045-8rifAMPin [Susceptibility] by Gradient stripL7046-6Roxithromycin [Susceptibility] by Gradient stripL7047-4Sparfloxacin [Susceptibility] by Gradient stripL7048-2Streptomycin [Susceptibility] by Gradient stripL7050-8sulfADIAZINE [Susceptibility] by Gradient stripL7051-6Teicoplanin [Susceptibility] by Gradient stripL7053-2Ticarcillin [Susceptibility] by Gradient stripL7054-0Ticarcillin+Clavulanate [Susceptibility] by Gradient stripL7055-7Tobramycin [Susceptibility] by Gradient stripL7056-5Trimethoprim [Susceptibility] by Gradient stripL7057-3Trimethoprim+Sulfamethoxazole [Susceptibility] by Gradient stripL7058-1Trovafloxacin [Susceptibility] by Gradient stripL71-1Cefatrizine [Susceptibility] by Minimum lethal concentration (MLC)L72-9Cefatrizine [Susceptibility] by Minimum inhibitory concentration (MIC)L72168-8Ofloxacin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 1.5 ug/mLL72276-9Mycobacterium tuberculosis gyrA gene fluoroquinolone resistance mutation [Presence] by Molecular methodL72834-5Foscarnet [Susceptibility] by Phenotype methodL72836-0Vancomycin resistance vanC2+vanC3 genes [Presence] by Molecular methodL72837-8Vancomycin resistance vanC1 gene [Presence] by Molecular methodL72839-4Famciclovir [Susceptibility] by Genotype methodL72840-2Hepatitis B virus codon 250 [Identifier] by Genotype methodL72841-0Hepatitis B virus codon 237 [Identifier] by Genotype methodL72842-8Hepatitis B virus codon 233 [Identifier] by Genotype methodL72843-6Hepatitis B virus codon 215 [Identifier] by Genotype methodL72844-4Hepatitis B virus codon 214 [Identifier] by Genotype methodL72845-1Hepatitis B virus codon 202 [Identifier] by Genotype methodL72846-9Hepatitis B virus codon 194 [Identifier] by Genotype methodL72847-7Hepatitis B virus codon 191 [Identifier] by Genotype methodL72848-5Hepatitis B virus codon 184 [Identifier] by Genotype methodL72849-3Hepatitis B virus codon 169 [Identifier] by Genotype methodL72850-1Hepatitis B virus codon 85 [Identifier] by Genotype methodL72851-9Hepatitis B virus codon 84 [Identifier] by Genotype methodL72853-5Maribavir [Susceptibility] by Genotype methodL72855-0Cidofovir [Susceptibility] by Phenotype methodL72858-4Enfuvirtide [Susceptibility] by Genotype methodL72861-8Ganciclovir [Susceptibility] by Phenotype methodL72863-4Mycobacterium leprae gyrB gene fluoroquinolone resistance mutation [Presence] by Molecular methodL72864-2Mycobacterium tuberculosis rpsL+rrs genes aminoglycoside resistance mutation [Presence] by Molecular methodL72865-9Mycobacterium tuberculosis ethB gene ethionamide resistance mutation [Presence] by Molecular methodL72866-7Mycobacterium tuberculosis ethA gene ethionamide resistance mutation [Presence] by Molecular methodL72867-5Mycobacterium tuberculosis gyrB gene fluoroquinolone resistance mutation [Presence] by Molecular methodL72868-3Mycobacterium leprae folP1 gene dapsone resistance mutation [Presence] by Molecular methodL72869-1Mycobacterium leprae gyrA gene fluoroquinolone resistance mutation [Presence] by Molecular methodL72870-9Mycobacterium leprae rpoB gene rifAMPin resistance mutation [Presence] by Molecular methodL72893-1Doripenem [Susceptibility] by Disk diffusion (KB)L73-7Cefatrizine [Susceptibility] by Disk diffusion (KB)L73574-6Acyclovir [Susceptibility] by Genotype methodL73585-2Tizoxanide [Susceptibility]L73586-0Tedizolid [Susceptibility]L73587-8Solithromycin [Susceptibility]L73588-6Sarafloxacin [Susceptibility]L73589-4rifAXIMin [Susceptibility]L73590-2Razupenem [Susceptibility]L73591-0Premafloxacin [Susceptibility]L73592-8Plazomicin [Susceptibility]L73593-6Ormetroprim+Sulfamethoxazole [Susceptibility]L73594-4Omadacycline [Susceptibility]L73595-1Nitazoxanide [Susceptibility]L73596-9Marbofloxacin [Susceptibility]L73597-7Iclaprim [Susceptibility]L73598-5Finafloxacin [Susceptibility]L73599-3Fidaxomicin [Susceptibility]L73600-9Faropenem [Susceptibility]L73601-7Danofloxacin [Susceptibility]L73603-3cefTAZidime+Avibactam [Susceptibility]L73604-1Ceftaroline+Avibactam [Susceptibility]L73605-8Ceftaroline [Susceptibility]L73606-6Besifloxacin [Susceptibility]L73607-4Tizoxanide [Susceptibility] by Minimum inhibitory concentration (MIC)L73608-2Tedizolid [Susceptibility] by Minimum inhibitory concentration (MIC)L73609-0Solithromycin [Susceptibility] by Minimum inhibitory concentration (MIC)L73610-8Sarafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)L73611-6rifAXIMin [Susceptibility] by Minimum inhibitory concentration (MIC)L73612-4Razupenem [Susceptibility] by Minimum inhibitory concentration (MIC)L73613-2Premafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)L73614-0Plazomicin [Susceptibility] by Minimum inhibitory concentration (MIC)L73615-7Ormetroprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)L73616-5Omadacycline [Susceptibility] by Minimum inhibitory concentration (MIC)L73617-3Nitazoxanide [Susceptibility] by Minimum inhibitory concentration (MIC)L73618-1Marbofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)L73619-9Iclaprim [Susceptibility] by Minimum inhibitory concentration (MIC)L73620-7Finafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)L73621-5Fidaxomicin [Susceptibility] by Minimum inhibitory concentration (MIC)L73622-3Faropenem [Susceptibility] by Minimum inhibitory concentration (MIC)L73623-1Danofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)L73626-4Ceftaroline+Avibactam [Susceptibility] by Minimum inhibitory concentration (MIC)L73628-0Besifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)L73629-8Tizoxanide [Susceptibility] by Disk diffusion (KB)L73630-6Telavancin [Susceptibility] by Disk diffusion (KB)L73631-4Tedizolid [Susceptibility] by Disk diffusion (KB)L73632-2Solithromycin [Susceptibility] by Disk diffusion (KB)L73633-0Sarafloxacin [Susceptibility] by Disk diffusion (KB)L73634-8rifAXIMin [Susceptibility] by Disk diffusion (KB)L73635-5Razupenem [Susceptibility] by Disk diffusion (KB)L73636-3Premafloxacin [Susceptibility] by Disk diffusion (KB)L73637-1Plazomicin [Susceptibility] by Disk diffusion (KB)L73638-9Ormetroprim+Sulfamethoxazole [Susceptibility] by Disk diffusion (KB)L73639-7Omadacycline [Susceptibility] by Disk diffusion (KB)L73640-5Nitazoxanide [Susceptibility] by Disk diffusion (KB)L73641-3Marbofloxacin [Susceptibility] by Disk diffusion (KB)L73642-1Iclaprim [Susceptibility] by Disk diffusion (KB)L73643-9Finafloxacin [Susceptibility] by Disk diffusion (KB)L73644-7Fidaxomicin [Susceptibility] by Disk diffusion (KB)L73645-4Faropenem [Susceptibility] by Disk diffusion (KB)L73646-2Danofloxacin [Susceptibility] by Disk diffusion (KB)L73649-6Ceftaroline+Avibactam [Susceptibility] by Disk diffusion (KB)L73650-4Ceftaroline [Susceptibility] by Disk diffusion (KB)L73651-2Besifloxacin [Susceptibility] by Disk diffusion (KB)L73652-0Apramycin [Susceptibility] by Minimum inhibitory concentration (MIC)L73653-8Apramycin [Susceptibility] by Disk diffusion (KB)L73656-1Varicella zoster virus ORF28 genotype [Identifier]L73657-9Varicella zoster virus ORF36 genotype [Identifier]L73665-2Optochin [Susceptibility] by Disk diffusion (KB)L74-5Cefatrizine [Susceptibility] by Serum bactericidal titerL74699-0Cefuroxime [Susceptibility] by Disk diffusion (KB)L75-2ceFAZolin [Susceptibility] by Minimum lethal concentration (MLC)L75029-9Zanamivir [Susceptibility] by Genotype methodL75753-4Vancomycin resistance vanD gene [Presence] by Molecular methodL76040-5levoFLOXacin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 1.0 ug/mLL76041-3levoFLOXacin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 2.0 ug/mLL76042-1levoFLOXacin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 4.0 ug/mLL76043-9Moxifloxacin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 0.5 ug/mLL76044-7Moxifloxacin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 1.0 ug/mLL76045-4Moxifloxacin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 2.0 ug/mLL76143-7Cefcapene [Susceptibility] by Minimum inhibitory concentration (MIC)L76144-5Cefteram [Susceptibility] by Minimum inhibitory concentration (MIC)L76145-2Prulifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)L76146-0Tosufloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)L76147-8Cefovecin [Susceptibility] by Minimum inhibitory concentration (MIC)L76148-6Pradofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)L76149-4Tulathromycin [Susceptibility] by Minimum inhibitory concentration (MIC)L76150-2Cefquinome [Susceptibility] by Minimum inhibitory concentration (MIC)L76627-9Rifapentine [Susceptibility] by Method for Slow-growing mycobacteriaL77162-6Anidulafungin [Susceptibility] by Gradient stripL77666-6Methicillin resistance mecA mRNA [Presence] by FISH in Positive blood cultureL77734-2Mycobacterium abscessus complex clarithromycin resistance erm(41) full length gene [Presence] by Molecular methodL77735-9Mycobacterium abscessus complex clarithromycin resistance erm(41) truncated gene [Presence] by Molecular methodL77736-7Mycobacterium abscessus complex clarithromycin resistance erm(41) gene [Interpretation] by Molecular methodL77960-3Penicillin Parenteral [Susceptibility] by Disk diffusion (KB)L78-6ceFAZolin [Susceptibility] by Serum bactericidal titerL78004-9Staphylococcus aureus.vancomycin resistance [Susceptibility] QualitativeL79-4Cefixime [Susceptibility] by Minimum lethal concentration (MLC)L8-3Amdinocillin [Susceptibility] by Minimum inhibitory concentration (MIC)L80688-5HIV 1 RNA tropism [Identifier] in PlasmaL81122-4HIV 1 RNA reverse transcriptase and protease gene [Nucleotide sequence] in Serum, Plasma or Blood by SequencingL82-8Cefixime [Susceptibility] by Serum bactericidal titerL82513-3Hepatitis C virus genotype 3 [Presence] in Serum or Plasma by NAA with probe detectionL8273-5Cefepime [Susceptibility] by Serum bactericidal titerL8274-3Cefpirome [Susceptibility] by Minimum lethal concentration (MLC)L8275-0Cefpirome [Susceptibility] by Minimum inhibitory concentration (MIC)L8276-8Cefpirome [Susceptibility] by Disk diffusion (KB)L83-6Cefaclor [Susceptibility] by Minimum lethal concentration (MLC)L83325-1HIV 1 RNA genotype in IsolateL83327-7HIV 1 RNA phenotype in IsolateL85043-8ESBL by cefepime to cefepime-clavulanate IC ratio [Presence] by ARD gradient stripL85045-3Staphylococcus aureus glycopeptide resistant based on vancomycin and teicoplanin IC [Identifier] by ARD gradient stripL85046-1AmpC beta-lactamase by cefoTEtan to cefoTEtan+cloxacillin inhibitory concentration ratio [Presence] by ARD gradient stripL85047-9MBL by meropenem to meropenem-EDTA IC ratio [Presence] by ARD gradient stripL85048-7Micafungin [Susceptibility] by Gradient stripL85049-5ESBL by cefotaxime to cefotaxime-clavulanate IC ratio [Presence] by ARD gradient stripL85050-3ESBL by ceftazidime to ceftazidime-clavulanate IC ratio [Presence] by ARD gradient stripL85051-1Telavancin [Susceptibility] by Gradient stripL85052-9Ceftobiprole [Susceptibility] by Gradient stripL85053-7MBL by imipenem to imipenem-EDTA IC ratio [Presence] by ARD gradient stripL85381-2Isavuconazole [Susceptibility] by Minimum inhibitory concentration (MIC)L85422-4ceFAZolin [Susceptibility] for UTI by Minimum inhibitory concentration (MIC)L85423-2Eravacycline [Susceptibility] by Minimum inhibitory concentration (MIC)L85424-0Imipenem+Relebactam [Susceptibility] by Minimum inhibitory concentration (MIC)L85425-7Lefamulin [Susceptibility] by Minimum inhibitory concentration (MIC)L85426-5Meropenem [Susceptibility] for meningitis by Minimum inhibitory concentration (MIC)L85427-3Meropenem+Vaborbactam [Susceptibility] by Minimum inhibitory concentration (MIC)L85428-1Penicillin [Susceptibility] for meningitis by Minimum inhibitory concentration (MIC)L85429-9Penicillin [Susceptibility] for pneumonia by Minimum inhibitory concentration (MIC)L85503-1Carbapenem resistance blaOXA-48 gene [Presence] by Molecular methodL85822-5Beta-lactam resistance AmpC blaCMY+blaMOX genes [Presence] by Molecular methodL85823-3Carbapenem resistance blaGES gene [Presence] by Molecular methodL85825-8Carbapenem resistance blaOXA-23-like gene [Presence] by Molecular methodL85826-6Carbapenem resistance blaOXA-24-like gene [Presence] by Molecular methodL85827-4Carbapenem resistance bla OXA-48-like gene [Presence] by Molecular methodL85828-2Carbapenem resistance blaOXA-58-like gene [Presence] by Molecular methodL85829-0Carbapenem resistance blaSPM gene [Presence] by Molecular methodL85831-6Beta-lactam resistance ESBL blaBEL gene [Presence] by Molecular methodL85832-4Beta-lactam resistance ESBL blaCTX-M-1 Group gene [Presence] by Molecular methodL85833-2Carbapenem resistance blaGIM gene [Presence] by Molecular methodL85834-0Beta-lactam resistance ESBL blaCTX-M-9 Group gene [Presence] by Molecular methodL85835-7Beta-lactam resistance ESBL blaCTX-M-8+blaCTX-M-25 Group genes [Presence] by Molecular methodL85836-5Beta-lactam resistance ESBL blaGES gene [Presence] by Molecular methodL85837-3Beta-lactam resistance ESBL blaPER gene [Presence] by Molecular methodL85838-1Beta-lactam resistance ESBL blaSHV gene [Presence] by Molecular methodL85839-9Beta-lactam resistance ESBL blaTEM gene [Presence] by Molecular methodL85840-7Beta-lactam resistance ESBL blaVEB gene [Presence] by Molecular methodL85841-5Beta-lactam resistance AmpC blaACC gene [Presence] by Molecular methodL85842-3Beta-lactam resistance AmpC blaACT+blaMIR genes [Presence] by Molecular methodL85843-1Beta-lactam resistance AmpC blaFOX gene [Presence] by Molecular methodL85844-9Beta-lactam resistance ESBL blaCTX-M-2 Group gene [Presence] by Molecular methodL86-9Cefaclor [Susceptibility] by Serum bactericidal titerL86221-9Colistin resistance mcr-1 gene [Presence] by Molecular methodL86620-2Methicillin resistance mecA+mecC genes [Presence] in Nose by NAA with probe detectionL86621-0Methicillin resistance mecC gene [Presence] by Molecular methodL86713-5Carbapenem resistance blaOXA-134-like gene [Presence] by Molecular methodL86714-3Carbapenem resistance blaOXA-51-like gene [Presence] by Molecular methodL87-7Cefmetazole [Susceptibility] by Minimum lethal concentration (MLC)L87735-7Ceftolozane+Tazobactam [Susceptibility] by Gradient stripL87790-2Carbadox [Susceptibility] by Minimum inhibitory concentration (MIC)L87791-0Carbadox [Susceptibility]L87792-8Cefovecin [Susceptibility]L87793-6Nitrofurazone [Susceptibility] by Minimum inhibitory concentration (MIC)L87794-4Furazolidone [Susceptibility] by Minimum inhibitory concentration (MIC)L87795-1Ormetoprim+Sulfadimethoxine [Susceptibility] by Minimum inhibitory concentration (MIC)L87796-9Sulfathiazole [Susceptibility] by Minimum inhibitory concentration (MIC)L87797-7Sulfathiazole [Susceptibility]L87798-5Tulathromycin [Susceptibility]L87799-3Sulfadimethoxine [Susceptibility] by Minimum inhibitory concentration (MIC)L87800-9Pradofloxacin [Susceptibility]L87801-7Ormetoprim+Sulfadimethoxine [Susceptibility]L87802-5Sulfachloropyridazine [Susceptibility]L87803-3Sulfadimethoxine [Susceptibility]L87804-1Sulfachloropyridazine [Susceptibility] by Minimum inhibitory concentration (MIC)L88-5Cefmetazole [Susceptibility] by Minimum inhibitory concentration (MIC)L88002-1Kanamycin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 2.5 ug/mLL88375-1Tildipirosin [Susceptibility] by Disk diffusion (KB)L88376-9Gamithromycin [Susceptibility] by Disk diffusion (KB)L88377-7Tildipirosin [Susceptibility] by Minimum inhibitory concentration (MIC)L88378-5Gamithromycin [Susceptibility] by Minimum inhibitory concentration (MIC)L88462-7Carbapenem [Susceptibility]L88509-5Helicobacter pylori 23S rRNA clarithromycin resistance mutation [Identifier] by Molecular methodL88542-6HIV 1 RNA integrase gene mutations detected [Identifier] in Cerebral spinal fluid by SequencingL88543-4HIV 1 RNA protease gene mutations detected [Identifier] in Cerebral spinal fluid by SequencingL88544-2HIV 1 RNA reverse transcriptase gene mutations detected [Identifier] in Cerebral spinal fluid by SequencingL88703-4Bedaquiline [Susceptibility] by Minimum inhibitory concentration (MIC)L88704-2Bedaquiline [Susceptibility] by Method for Slow-growing mycobacteriaL88705-9Kanamycin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 3.5 ug/mLL88706-7Linezolid [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 1.0 ug/mLL88707-5Moxifloxacin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 0.25 ug/mLL88886-7Telavancin [Susceptibility]L88887-5Isavuconazole [Susceptibility]L88892-5Meropenem+Vaborbactam [Susceptibility]L89-3Cefmetazole [Susceptibility] by Disk diffusion (KB)L89314-9Bacterial 23S rRNA gene azithromycin resistance mutation [Presence] by Molecular methodL89480-8Azithromycin [Susceptibility] by Genotype methodL89481-6Gentamicin [Susceptibility] by Genotype methodL89482-4Kanamycin [Susceptibility] by Genotype methodL89483-2Capreomycin [Susceptibility] by Genotype methodL89484-0Amikacin [Susceptibility] by Genotype methodL89485-7Clarithromycin [Susceptibility] by Genotype methodL89487-3Fluoroquinolone [Susceptibility] by Genotype methodL89488-1Isoniazid [Susceptibility] by Genotype methodL89489-9rifAMPin [Susceptibility] by Genotype methodL89490-7Aminoglycoside [Susceptibility] by Genotype methodL89491-5Ethambutol [Susceptibility] by Genotype methodL9-1Amdinocillin [Susceptibility] by Disk diffusion (KB)L90-1Cefmetazole [Susceptibility] by Serum bactericidal titerL90080-3Bictegravir [Susceptibility] by Genotype methodL90849-1Cefpodoxime [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 4.0 ug/mLL90850-9cefTAZidime [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 1.0 ug/mLL90980-4Meropenem+Vaborbactam [Susceptibility] by Gradient stripL91-9Cefodizime [Susceptibility] by Minimum lethal concentration (MLC)L91897-9Doravirine [Susceptibility] by Genotype methodL92-7Cefodizime [Susceptibility] by Minimum inhibitory concentration (MIC)L92241-9Vancomycin [Susceptibility] by Genotype methodL92242-7Pyrazinamide [Susceptibility] by Genotype methodL92243-5Microorganism resistance mutation tested for by Molecular methodL92244-3Microorganism resistance mutation nucleic acid change type by Molecular methodL92245-0Microorganism resistance mutation nucleic acid change by Molecular methodL92246-8Microorganism resistance mutation detected [Presence] by Molecular methodL92247-6Microorganism resistance mutation amino acid change type by Molecular methodL92248-4Microorganism resistance mutation amino acid change by Molecular methodL92249-2Microorganism gene tested for [Identifier] by Molecular methodL92250-0Microorganism gene target region [Type] by Molecular methodL92251-8Microorganism gene detected [Presence] by Molecular methodL92255-9Methicillin [Susceptibility] by Genotype methodL92733-5Glecaprevir [Susceptibility] by Genotype methodL92734-3Voxilaprevir [Susceptibility] by Genotype methodL92735-0Pibrentasvir [Susceptibility] by Genotype methodL93-5Cefodizime [Susceptibility] by Disk diffusion (KB)L93232-7Imipenem+Relebactam [Susceptibility] by Gradient stripL93497-6Moxifloxacin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 3.0 ug/mLL93699-7Beta-lactam resistance AmpC blaCMY-2 gene [Presence] by Molecular methodL93700-3Beta-lactam resistance AmpC blaDHA gene [Presence] by Molecular methodL93701-1Colistin resistance mcr-2 gene [Presence] by Molecular methodL93767-2Eravacycline [Susceptibility] by Gradient stripL93850-6Pretomanid [Susceptibility]L93851-4Delamanid [Susceptibility]L94-3Cefodizime [Susceptibility] by Serum bactericidal titerL94054-4Bacterial katG gene drug resistance mutation [Identifier] by Molecular methodL94055-1Bacterial inhA gene drug resistance mutation [Identifier] by Molecular methodL94056-9Bacterial fabG1 gene drug resistance mutation [Identifier] by Molecular methodL94057-7Bacterial ahpC gene drug resistance mutation [Identifier] by Molecular methodL94058-5Bacterial embB gene drug resistance mutation [Identifier] by Molecular methodL94059-3Bacterial pncA gene drug resistance mutation [Identifier] by Molecular methodL94060-1Bacterial gyrA gene drug resistance mutation [Identifier] by Molecular methodL94061-9Bacterial gidB gene drug resistance mutation [Identifier] by Molecular methodL94062-7Bacterial rrs gene drug resistance mutation [Identifier] by Molecular methodL94063-5Bacterial rpsL gene drug resistance mutation [Identifier] by Molecular methodL94064-3Bacterial eis gene drug resistance mutation [Identifier] by Molecular methodL94065-0Bacterial rpoB gene drug resistance mutation [Identifier] by Molecular methodL94274-8Bedaquiline [Susceptibility]L94424-9Staphylococcus aureus methicillin resistance SCCmec+orfX junction [Presence] by Molecular methodL94719-2Plazomicin [Susceptibility] by Gradient stripL95-0Cefonicid [Susceptibility] by Minimum lethal concentration (MLC)L95540-1Carbapenem resistance blaIMP+blaVIM genes [Presence] by Molecular methodL95767-0Cefiderocol [Susceptibility] by Disk diffusion (KB)L95809-0Carbapenem resistance genes [Presence] by Molecular methodL96-8Cefonicid [Susceptibility] by Minimum inhibitory concentration (MIC)L96107-8Bedaquiline [Susceptibility] by Genotype methodL96108-6Clofazimine [Susceptibility] by Genotype methodL96109-4Delamanid [Susceptibility] by Genotype methodL96110-2Ethionamide [Susceptibility] by Genotype methodL96111-0Linezolid [Susceptibility] by Genotype methodL96112-8Moxifloxacin [Susceptibility] by Genotype methodL96113-6Rifabutin [Susceptibility] by Genotype methodL96114-4Streptomycin [Susceptibility] by Genotype methodL96309-0Methicillin resistance mecA+mecC genes+SCCmec+OrfX junction [Presence] by Molecular methodL96372-8Imipenem+Relebactam [Susceptibility]L96566-5Cabotegravir [Susceptibility] by Genotype methodL98-4Cefonicid [Susceptibility] by Serum bactericidal titerL98063-1Beta-lactam resistance ESBL blaCTX-M-15 gene [Presence] by Molecular methodL98064-9Beta-lactam resistance ESBL blaCTX-M-14 gene [Presence] by Molecular methodL98065-6Carbapenem resistance blaOXA-143 gene [Presence] by Molecular methodL98066-4Colistin resistance mcr-3+mcr-4+mcr-5 genes [Presence] by Molecular methodL99-2Cefoperazone [Susceptibility] by Minimum lethal concentration (MLC)L99034-1Trimethoprim resistance dfrA1 gene [Presence] by Molecular methodL99035-8Trimethoprim resistance dfrA5 gene [Presence] by Molecular methodL99036-6Trimethoprim resistance dfrA7+dfrA17 genes [Presence] by Molecular methodL99037-4Trimethoprim dfrA12 gene [Presence] by Molecular methodL99280-0Cefiderocol [Susceptibility]L99281-8Lefamulin [Susceptibility]L99503-5Cefiderocol [Susceptibility] by Minimum inhibitory concentration (MIC)L99780-9Multidrug resistant gram-negative organism classification [Type]L